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Eight chiral ionic liquids have been prepared for use as solvents to test whether they can 
induce enantioselectivity in both photochemical [2+2] cycloadditions and aldol reactions using a 
variety of starting materials. The chiral ionic liquids include 1-butyl-3-methylimidazolium L-
lactate (chiral anion), 1-butyl-3-methylimidazolium camphorsulfonate (R and S chiral anions), 2-
amino-N,N,N-trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate (R and S chiral cations), 1-
butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (chiral cation), 1-
[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (chiral cation), and 1-butyl-3-
[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide (chiral cation). The stability of each chiral 
ionic liquid was tested to ensure they were well suited for both reaction types. To date, the eight 
chiral ionic liquids have been used as solvents to impart enantioselectivity in 28 photoadditions 
and 22 aldol reactions. Specific rotations of the purified products have been obtained. Enhanced 
optical activity was seen when switching from the achiral environment that utilized classical 
  
organic solvents to the chiral environment that utilized chiral ionic liquids as the solvent. 
Enantiomeric excesses could not be calculated. All products have been characterized by gas 
chromatography (GC), infrared (IR) spectrometry, mass spectrometry (MS), and most of them by 
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Chapter One: Chiral Ionic Liquid Review 
1.1 Introduction  
 Ionic liquids (ILs) are organic salt-like materials that are liquid under 100℃ due to poorly 
coordinated ions. They are typically constituted by large nonasymmetric cations with weakly 
coordinating organic or inorganic anions. [1] Examples of frequently used cations include 
imidazolium, pyridinium, pyrrolidinium, ammonium, and phosphonium. Examples of frequently 
used coordinating anions include tetrafluoroborate, hexafluorophosphate, lactate, 
camphorsulfonate, and bistriflateimide. This unique interaction allows ILs to function as an 
attractive medium for many synthetic and chemical processes. [2] 
 
Figure 1. Common cations and anions in ILs. [2] 
 A novel property of ILs is that they are “designer solvents” allowing them to be 
modulated to suit specific reaction conditions. Their physical properties can be tuned to optimize 
yield, substrate solubility, product separation and even enantioselectivity. Altering either the 
cation, anion, or their substituents, allows for manipulation of properties such as polarity, 
hydrophobicity, viscosity, and solvent miscibility. [3] For instance, it was demonstrated that an IL 
consisting of the cation 1-alkyl-3-alkylimidazolium and the anion PF6
 – can be made more 
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soluble in water by replacing the anion with BF4
-. Conversely, replacement of the anion with 
Tf2N
- dramatically decreases the solubility of the IL in water. Another example demonstrated 
that hydrophobicity may be altered in an IL by changing the chain length of the cation or the 
identity of the anion. By changing the 1-alkyl chain on 1-alkyl-3-methyl-imidazolium 
hexafluorophosphate from one carbon in length to nine carbons results in the IL changing from 
being soluble in water to very insoluble. [4] A decrease in the IL melting point can be achieved in 
two ways. First, asymmetry can be introduced on the cation of the IL by adding longer or shorter 
chains. Second, the longer chains of the IL can be branched, which results in poorer packing of 
the material, therefore, lower melting points. [5]  
 The history of ILs dates back to the early 1900s. The first low-melting salt, 
ethylammonium nitrate, was proposed by Walden in 1914. [6] It had a low melting point of 12℃. 
During the 1970s and 1980s, ILs were mostly studied for their applications in electrochemistry. 
[4] These studies focussed on their properties such as good ionic conductivity, a wide 
electrochemical potential window, high viscosities, high thermal stabilities, and tunable solvent 
properties. [7] Their application to organic synthesis was first proposed by Fry and Pienta, and 
Boon et al. [8,9] In the 1990s, the name room-temperature ILs was assigned to describe these 
molten salts. It was estimated by Earle and Seddon that the number of possible ILs must be in the 
order of 1 billion. [4] In 1992, ILs became a trending topic when Wilkes and Zaworotko reported 
the synthesis of imidazolium-based salts, which demonstrated unique and desirable properties. 
Using imidazolium as the cation in ILs provides salts with low melting points, good chemical 
and thermal stabilities, and favourable viscosities. These properties directly improve the ILs 
reusability and thus, make imidazolium a frequently used cation. [10] 
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1.2 ILs as Green Solvents             
 ILs have attracted increasing interest recently for their application in green chemistry due 
to an increase in environmental consciousness in chemical research and industry. ILs have 
emerged as a promising, environmentally friendly alternative to traditional organic solvents. 
Traditional solvents are volatile and pose many negative health effects and environmental 
concerns such as atmospheric emissions and contamination of water effluents. [11,12] ILs have a 
negligible vapour pressure and thus, do not contribute volatile organic compounds (VOCs) into 
the atmosphere. This property alone characterizes them as environmentally friendly solvents. 
Other properties such as their non-flammability, and good chemical and thermal stability also 
contribute to their environmentally friendly nature. [13] ILs are also advantageous over traditional 
solvents as they contain a high liquid range up to more than 300 K, they have a density greater 
than water and can dissolve a wide range of substances. [4,14] As it is an ionic interaction between 
the cations and anions in the salt that define the properties of these solvents, they are very 
miscible with a large range of substances with different polarities. Traditional organic solvents 
have interactions such as hydrogen-bonding, dipole-dipole and van der Waals interactions and 
thus, contain a limited liquid range and miscibility. [4] Therefore, some processes that can be 
achieved with ILs are not possible with traditional organic solvents.  
 Another property of ILs that classifies them as green solvents is their recyclability. This 
desirable property allows ILs to be recycled and reused a number of times without losing their 
functionality. The organic components in the flask can be extracted from the IL by the use of a 
non-polar organic solvent. This property of recyclability can be attributed to their negligible 
vapour pressure. In research applications, the recycling process of ILs varies from quite poor to 
very good. [2] The first enantioselective Diels-Alder reaction performed by Doherty at al. in 2007 
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reported that their imidazolium tagged bis(oxazoline) chiral ionic liquid (CIL) could be reused 
up to 10 times without losing its functionality. [15] In another Diels-Alder reaction performed by 
Wang and coworkers in 2010 reported that their 2-pyrrolidinecarboxylic acid-derived CIL could 
be reused six times without losing its functionality. [16] 
1.3 CILs in Asymmetric Synthesis 
 Chiral ionic liquids are ILs that contain a chiral cation and/or a chiral anion. When used 
as solvents they were found to give unique selectivities and have the potential for chiral 
discrimination capabilities. The first CIL was synthesized in 1996 by Herrmann et al. during 
their synthesis of N-heterocyclic carbenes of imidazoles. [17] During these reactions, an 
imidazolium chloride CIL was produced as an intermediate. The first successful application 
using a CIL to show selectivity in a reaction was in 2004 by Vo-Thanh and coworkers (Scheme 
1). [18] They were able to achieve 44% enantiomeric excess in a Baylis-Hillman reaction using an 
ephedrinium CIL with benzaldehyde and methyl acrylate. The reaction was catalyzed by 1,4-
diazabicyclo[2.2.2]octane (DABCO). This was the largest reported enantiomeric excess using 
CILs in any asymmetric synthesis before 2005. 
 
Scheme 1. Asymmetric Baylis-Hillman reaction using an ephedrinium CIL. 
In 2007, Doherty et al. reported the first enantioselective Diels-Alder reaction of N-acryloyl- and 
N-crotonyloxazolidinones with cyclopentadiene and 1,3-cyclohexadiene using an imidazolium 
tagged bis(oxazoline) CIL. Specifically, in a reaction with 3-acryloyl-1,3-oxazolidin-2-one and 
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cyclopentadiene they were able to achieve 84% enantiomeric excess and endo:exo ratio of 88:12 
(Scheme 2). [15]  
 
Scheme 2. Asymmetric Diels-Alder reaction with an imidazolium tagged bis(oxazoline). 
In 2007, Headey and coworkers synthesized a pyrrolidine based CIL that successfully induced 
enantioselectivity in a Michael addition between aldehydes and nitrostyrenes (Scheme 3). They 
achieved good enantioselectivities of 82% enantiomeric excess and high diastereoselectivies of 
syn:anti ratio of 97:3. [19] 
 
Scheme 3. Asymmetric Michael addition using a pyrrolidine based CIL. 
Many other reactions have been reported in literature that used CILs to induce enantioselectivity 
successfully. These reactions include the asymmetric aldol reaction, enantioselective 
hydrogenation and the Bignelli reaction. [10] 
1.4 Importance of Controlling Stereochemistry 
 Controlling stereochemistry is very important in drug design. Currently, more than half 
the drugs in clinical use are chiral. The pharmacological activity of a drug depends mainly on its 
interaction with the biological target. Although enantiomers have the same physical properties, 
most enantiomeric pairs of drugs exhibit great differences in their pharmacology. [1] For 
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example, it is common that the undesired enantiomer can be biologically inactive. This is 
exhibited with the well-known painkiller, ibuprofen, where the S-enantiomer demonstrates the 
desired anti-inflammatory and pain-killing effects while the R-enantiomer is biologically 
inactive. [2]  
 
Figure 2. The enantiomers of ibuprofen. 
Moreover, the undesired enantiomer can be toxic or have undesirable side-effects. A classic 
example to illustrate this is the thalidomide disaster in the early 1960’s. Thalidomide was a 
sedative introduced into the market as a racemic mixture. A large population of pregnant women 
took thalidomide and gave birth to babies with deformities. When taken orally, even if a single 
enantiomer was present, it epimerized under the acidic conditions in the stomach. It was later 
discovered the R-enantiomer produced the desired sedative effects while the S-enantiomer 
produced the undesired embryo-toxic effects. [3]   
 
Figure 3. The enantiomers of thalidomide.  
Today, it is very difficult to obtain drug approval for a racemic mixture. Typically, only 
the active enantiomer can be present for the drug to be approved. Racemic mixtures are no 
longer put out on the market unless both enantiomers are proven safe. Therefore, finding an 
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efficient way to synthesize only one, or predominately one, enantiomer is very important. 
Further, being capable of synthesizing only one enantiomer is a greener process, as half of the 
sample is wasted as the undesired isomer must be removed from the racemic product mixture 
and discarded.   
This literature review demonstrates that enantioselectivity can successfully be imparted 
on various chemical reactions through the use of CILs as green solvents. The objective of this 
thesis is to synthesize suitable CILs for use as a solvent to impart enantioselectivity in both 
photochemical [2+2] cycloadditions and aldol reactions. The synthesis and stability of the chosen 
CILs will be discussed in Chapter Two. Additionally, two reaction types of interest, 
photochemical [2+2] cycloadditions and aldol reactions, will be discussed in Chapters Three and 














Chapter Two: Synthesis and Stability of CILs 
2.1 Introduction  
 The presence of CILs in the reactions is intended to have multiple roles. The CILs will 
function as the reaction solvent to provide a recyclable, low volatility alternative to classical 
organic solvents. The CILs are also being tested for their ability to transfer the solvent chirality 
to the achiral starting materials, resulting in chiral products. In this capacity they are functioning 
in place of a chiral catalyst. With this function in mind, the CIL cannot undergo any permanent 
change during the course of the reaction. Although it is possible the CIL may function to speed 
up the rate of the reaction, this will not be considered during the course of the study. 
The CILs chosen for use were selected by using specific criteria to ensure that they are 
stable to the different reaction conditions to which they will be subjected. The two reaction types 
being studied in this thesis are photochemical [2+2] cycloadditions and aldol reactions. 
Photochemical [2+2] cycloadditions proceed when the reagents are subjected to UV light and, 
thus, when selecting the CILs for these reactions they must have a UVmax value below the 
transmission cut off for Pyrex (275 nm). This ensures they will not interfere with the [2+2] 
photochemical reaction being studied by decreasing the light energy available for 
photoabsorption by the reagents. Furthermore, if the CILs do absorb UV light, their chirality 
cannot be impacted. Moreover, the aldol reaction requires the use of a base to facilitate the 
reaction. Optically active compounds containing an acidic hydrogen at the chiral center can be 
epimerized in the presence of a base. With the optical activity destroyed, the CIL will lose one of 
its functions. Thus, CILs without an acidic hydrogen at the chiral center were chosen for the 
aldol reaction. Chiral stability tests were performed on all chiral ionic liquids and are discussed 
in Chapter 2.2.2. 
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2.2 Results & Discussion 
2.2.1 Synthesis of CILs 
Eight chiral ionic liquids have been prepared for use as solvents to test whether they can 
induce enantioselectivity in both photochemical [2+2] cycloadditions and aldol condensations. 
Each CIL was synthesized according to literature procedures. The CILs include 1-butyl-3-
methylimidazolium L-lactate (1, chiral anion) [20] , 1-butyl-3-methylimidazolium 
camphorsulfonate (2R and 2S, R and S chiral anions) [20], 2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate (3R and 3S, R and S chiral cations) [21], 1-butyl-3-
menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4, chiral cation) [22], 1-[(3R)-
3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (5, chiral cation) [23], and 1-butyl-3-
[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide (6, chiral cation) [23]. Their respective 
reaction schemes are as follows:  
 
Scheme 4. Reaction scheme of the synthesis of 1-butyl-3-methylimidazolium L-lactate. 
 
Scheme 5. Reaction scheme of the synthesis of 1-butyl-3-methylimidazolium camphorsulfonate. 
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Scheme 6. Reaction scheme of the synthesis of 2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate. 
 
Scheme 7. Reaction scheme of the synthesis of 1-butyl-3-menthoxymethylimidazolium 
bis(trifluoromethanesulfonyl)amide. 
 




Scheme 9. Reaction scheme of 1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide. 
 To ensure each CIL was successfully synthesized, the specific rotation of each CIL was 
measured and compared to literature values (Table 1). The specific rotations of each synthesized 
CILs were very close to literature values and thus, the CILs were successfully synthesized.  
Table 1. Experimental and literature specific rotation values for each synthesized CIL. 
 CIL [] []lit 
1 1-butyl-3-methylimidazolium L-lactate [24] -5.17° -4° to -6° 
2R 1-butyl-3-methylimidazolium (R)-camphorsulfonate [20] -20.24° -22° 

















Additionally, each chiral ionic liquid was characterized via infrared (IR) spectroscopy, 
mass spectrometry (MS) and compared to the literature values. All of the characterization data 
was in keeping with the literature values. 
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2.2.2 Stability of CILs 
 Two chiral stability tests were performed on each CIL to ensure that they would not react 
under either the photochemical or aldol addition reaction conditions. To examine their suitability 
for the photochemical reaction conditions, 1 mL of each CIL was placed into a Pyrex irradiation 
tube and irradiated with a Hg-vapor lamp for 24 hours. The specific rotation after the chiral 
stability test showed little to no change with each synthesized CIL and thus, each CIL is stable to 
use for the photochemical [2+2] cycloadditions. The specific rotations are reported in Table 2. 
To examine their suitability for the aldol reactions, 1 mmol of the base, pyrroldine, was added to 
1 mL of each CIL and the mixture was allowed to stir overnight. The base was removed by the 
rotatory evaporator and the specific rotations were taken. The specific rotations after the chirality 
stability test showed little to no change with each synthesized CIL except for 1-butyl-3-
methylimidazolium L-lactate. Therefore, almost all of the CILs are stable for use. 1-butyl-3-
methylmidazolium L-lactate will not be used for the aldol reactions. It contains an acidic 
hydrogen at its chiral center and thus, was partially racemized by the base pyrrolidine. The 










Table 2. Specific rotations of each synthesized CIL before and after both chiral stability tests. 
 Photochemical Aldol 
Entry CIL []a []b []a []c 
1 1-butyl-3-methylimidazolium L-lactate 
(1) 
-5.17° -5.39° -3.94° -0.210° 
2 1-butyl-3-methylimidazolium (R)-
camphorsulfonate (2R) 
-20.02° -18.32° -19.04° -22.91° 
3 1-butyl-3-methylimidazolium (S)-
camphorsulfonate (2S) 
18.30° 18.14° 19.71° 19.24° 
4 (R)- 2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate (3R) 
-9.36° -9.19° -10.52° -10.48° 
5 (S)- 2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate (3S) 
7.80° 7.63° 7.80° 7.46° 
6 1-butyl-3-menthoxymethylimidazolium 
bis(trifluoromethanesulfonyl)amide (4) 
53.43° 50.83° 53.43° 49.28° 
7 1-[(3R)-3,7-dimethyloct-6-enyl]-3-
methyl-1H-imidazolium bromide (5) 
1.29° 1.21° 1.29° 1.13° 
8 1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-
imidazolium bromide (6) 
2.21° 2.17° 2.21° 2.09° 
a: reference optical rotation 
b: specific rotation after photochemical chiral stability test. 
c: specific rotation after aldol chiral stability test. 
 
 It is important to note that the starting CILs for the stability testing came from different 
synthetic batches which explains the different starting rotations. It was found, particularly with 
the camphor sulfonate ionic liquids, that the removal of the reaction solvent, acetone, proved to 
be difficult and resulted in minor variations in the rotations of the CILs used in the experiments, 
as their level of purity was different. For each chiral stability test, the reported starting rotation 
relates to the specific batch of CIL used.  
 Additionally, to ensure that the CIL would not interfere with the photoaddition, the 
UVmax of each CIL was measured (Table 3). Each CIL had a UVmax value below the 





Table 3. UVmax of each synthesized CIL. 
CIL UVmax (nm) 
1-butyl-3-methylimidazolium L-lactate 229 
1-butyl-3-methylimidazolium (R)-camphorsulfonate 225 

















 All eight CILs that were prepared are suitable for use under the reaction conditions for 
photochemical [2+2] cycloadditions and will be used as solvents to test whether or not they can 
impart enantioselectivity in the products. This will be discussed in Chapter Three. With regards 
to the aldol additions, seven CILs were suitable for use under the reaction conditions and will be 
used as solvents to test whether or not they can impart enantioselectivity in the products. The 
exception is 1-butyl-3-methylimidazolium L-lactate, which was partially racemized by the base 










Chapter Three: Photochemical [2+2] Cycloadditions 
3.1 Introduction  
 The photochemical [2+2] addition is the most important and frequently used 
photochemical reaction. It is a cycloaddition that usually occurs between an enone and an alkene 
that proceeds via a non-concerted mechanism. The conjugated enone absorbs UV light that will 
promote a 𝜋 electron from the highest occupied molecular orbital (HOMO) to the lowest 
unoccupied molecular orbital (LUMO), now termed the excited state (HOMO*). The 
photoexcitation of the enone results in it entering a very short-lived singlet excited state in which 
intersystem crossing to the triplet state will occur. The enone in its excited triplet state will 




Orbitals in phase and react
 
Figure 4. Molecular orbital depiction of a photochemical [2+2] addition.  
 Stereochemistry in this reaction is controlled by steric interactions in the transition state. 
Cyclobutane is strained and thus, a trans ring fusion will be less likely to occur. Further, cis-anti-
cis products will be more likely to occur due to steric interactions. Regiochemistry is controlled 
by a number of factors. The original hypothesis, known as “Corey’s Exciplex Theory” stated that 
the excitation reversed the ground state polarity of the molecule and thus, the molecules would 
react based on their relative dipoles. However, subsequent investigations have shown a solvent 
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and ring size dependence. The stability of biradical intermediate explains the regiochemistry 
favouring the most resonance stable intermediate. If both the alkene and the enone are 
substituted, then there is the possibility of 16 products. [28] 
Photochemical [2+2] cycloadditions are an exceptionally powerful tool for synthetic 
organic chemists. Four-membered rings are almost exclusively formed in these reactions. As 
well, these photoadditions provide access to the formation of larger ring systems via facile ring 
expansion/fragmentation of the strained cyclobutane ring. This ability to further react under 
controlled conditions has allowed them to become a key intermediate in syntheses involving 
multiple ring systems of structurally complex molecules. A drawback of this reaction is that it 
suffers from relatively poor regio- and stereocontrol and asymmetric induction is rarely reported 
in literature for this reaction. Having an efficient method of influencing the stereochemical 
outcome of these reactions would make them a more useful synthetic tool in organic synthesis. 
[28] 
There are few enantioselective photochemical reactions presented in the literature 
utilizing a chiral auxiliary, chiral catalyst or CILs. In 2002, Lange at al. presented an 
enantioselective [2+2] photoaddition using a chiral auxiliary. The researchers used cyclopentene 
and three different chiral synthons with different ketal auxiliaries in dichloromethane to perform 
the reaction. The reaction produced cis-anti-cis diastereomers with stereoselectivities up to 6:1, 







Scheme 10. Diastereoselective [2+2] photoaddition using a chiral ketal auxiliary.   
Another example was demonstrated in 2018 by Bach and Poplata. They performed a 
photochemical [2+2] addition with cyclic enones and alkenes using a chiral oxazaborolidine-
AlBr3 Lewis acid catalyst. Their results showed moderate to good yields ranging between 42-
82% and they had good levels of enantiocontrol from 82-96% enantiomeric excess. [30] 
 
Scheme 11. Enantioselective photochemical [2+2] addition using a Lewis acid catalyst. 
 The last example is a photochemical reaction presented in a CIL. Armstrong et al. 
employed a variety of CILs to induce enantioselectivity in a photoisomerization of 
dibenzobicyclo[2.2.2]octatrienes. They achieved yields from 60-97% and had low enantiomeric 
excess that ranged between 3-12%. [31] 
 
Scheme 12. Enantioselective photoisomerization using a CIL. 
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Photochemical [2+2] cycloadditions are a very important synthetic tool for organic 
chemists. Although few enantioselective photochemical reactions exist in literature, controlling 
the chiral outcome of the product would be extremely useful, and the use of CILs to impose 
enantioselectivity in this reaction needs to be explored.  
3.2 Results & Discussion 
3.2.1 Photochemical [2+2] Cycloadditions 
 Nine photochemical [2+2] cycloadditions have been performed in an achiral environment 
using the traditional organic solvent dichloromethane. A variety of different enones and alkenes 
have been chosen for use. The structures of the reagents are as follows: 
 
Figure 5. The name and structure of the various enones and alkenes used. 
Each enone was reacted separately with the alkenes, cyclopentene and cyclohexene. Further, 2-
cyclohexenone was reacted with an additional alkene, 1,1-dichloroethylene. The name and 
structures of the products are as follows: 
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Figure 6. The name and structure of each photoadduct. 
 
 These reactions were completed successfully. Each reaction was characterized via gas 
chromatography (GC), infrared (IR) spectroscopy, mass spectrometry (MS), 1H NMR 
spectroscopy and the data were compared to the literature values.  
Additionally, the specific rotations of each reaction were taken to ensure that they were 
not optically active as they were completed in an achiral environment. The specific rotations are 
presented in Table 4.  
Table 4. Specific rotations of each photochemical [2+2] addition product obtained using 
dichloromethane as the solvent. 
Entry Product Specific Rotation 
1 7 -0.74 ± 0.562 
2 8 -1.55 ± 1.56 
3 9 -0.40 ± 0.403 
4 10 -0.17 ± 0.341 
5 11 -3.47 ± 3.71 
6 12 0 ± 0 
7 13 -1.01 ± 0.997 
8 14 -0.79 ± 0.80 
9 15 -1.05 ± 0.959 
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Using error analysis taking into consideration the error associated with the polarimeter 
(Appendix), volumetric flask, and balance, most of the specific rotations can be seen as 0. The 
exceptions include products 7, 13, and 15 and their specific rotations after taking error analysis 
into account are 0.177, 0.013, and 0.09, respectively. These values are extremely close to 0 and 
the products are assumed to not be optically active. 
In conclusion, the specific rotations in Table 4 confirms that every reaction completed in 
the achiral environment is not optically active and in turn, guarantees that any degree of rotation 
exhibited by the reactions completed in the CILs is a result of the chiral environment.   
3.2.2 Asymmetric Photochemical [2+2] Cycloadditions 
 Twenty-eight photochemical [2+2] cycloadditions were performed using seven different 
CILs as solvents in an attempt to induce enantioselectivity. The same combination of reagents 
from the photochemical [2+2] cycloadditions in the achiral environment using dichloromethane 
were used. All reactions were completed with 1-butyl-3-methylimidazolium L-lactate (1) and 1-
butyl-3-methylimidazolium R-camphorsulfonate (2R). Two additional reactions were each 
completed using 1-butyl-3-methylimidazolium S-camphorsulfonate (2S), R-2-amino-N,N,N-
trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate (3R), 1-butyl-3-
menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4), 1-[(3R)-3,7-dimethyloct-
6-enyl]-3-methyl-1H-imidazolium bromide (5), and 1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-
imidazolium bromide (6) as the reaction solvents. The specific rotations and associated error of 





Table 5. Specific rotations of each photochemical [2+2] addition product obtained using seven 
CILs as the solvents. 
 CIL 
Entry Product 1 2R 2S 3R 4 5 6 
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Comparing these specific rotations to the photoadditions completed in the achiral 
environment, enhanced optical activity is seen. All CILs used with the exception of 1-butyl-3-
menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4) yielded products with 
negative specific rotations. Interestingly, both R- and S- enantiomers of 1-butyl-3-
methylimidazolium camphorsulfonate (2R, 2S) yielded products with negative specific rotations. 
Both 1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (5) and 1-butyl-3-
[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide (6) have positive specific rotations and 
yielded products with negative specific rotations. It is important to note that this ensures the CIL 
was fully removed from the product and any optical activity displayed did not come from 
residual CIL as the S-enantiomers produced products with negative rotations. A limited number 
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of reagent combinations were investigated (Table 5, entries 3-9) and these reaction combinations 
need to be completed to provide a larger number of data points.  
Generally, there is no specific trend that can be seen between the CILs and the specific 
rotations, although, a few single reactions can be highlighted. When 1-butyl-3-
methylimidazolium L-lactate (1) was used as solvent to impart enantioselectivity on product 7, 
the specific rotation was calculated to be -12.86 ± 3.06. Also, when 1-butyl-3-
menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4) was used as a solvent to 
impart enantioselectivity on product 7, the specific rotation was calculated to be 29.13 ± 1.74. 
Also, when 1-butyl-3-methylimidazolium R-camphorsulfonate (2R) was used as a solvent to 
impart enantioselectivity on product 9, the specific rotation was calculated to be -15.0 ± 4.10. 
Last, when 1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (5) was used to 
impart enantioselectivity on product 7, the specific rotation was calculated to be -10.87 ± 4.83. 
These specific rotations are of significantly higher magnitude than any of the others when 
performed in the respective CIL. For more reliable data, these reactions should have been 
repeated more than once. This was not completed due to time constraints. Replication would 
allow for better visualization of any patterns or general trends that exists between the CILs used 
and the optical activity of the products.  
 A chiral column for GC was purchased to measure the enantiopurity of each product but 
due to time constraints (COVID-19), no samples were analyzed. Compound 11 is the only 
product that has an optical rotation provided in the literature for comparison. [30] The researchers 
used a GC with a chiral column to analyze their product which gave a reported specific rotation 
of [α]D 
25 = +112 (1S,6S)-7,7-dichlorobicyclo[4.2.0]octan-2-one) and a calculated enantiomeric 
excess of 83%. Using their values, calculated ee of 3.3% and 2.4% were obtained for 1-butyl-3-
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methylimidazolium L-lactate (1) and 1-butyl-3-methylimidazolium R-camphorsulfonate (2R), 
respectively. Their product is the (+)-(1S,6S) and based on our negative rotations we assign the 
product to be (–)-(1R,6R). 
 
Figure 7. The product (–)-(1R,6R)-7,7-dichlorobicyclo[4.2.0]octan-2-one. 
Asymmetric photochemical [2+2] cycloadditions have the potential to produce up to 8 
enantiomeric pairs if either the alkene or enone is substituted, as there can be up to 4 new 
stereocenters produced. Enantiomers rotate plane-polarized light in equal and opposite 
directions. If any product contains an unequal mixture of enantiomers, this will affect the 
magnitude of the optical rotation. Therefore, although some of the specific rotations appear to 
have a small magnitude, this may be due to the product containing an enantiomeric pair in 
unequal concentrations.  
After column chromatography, few products were collected in very low yields and in 
combination with the soon to be decommissioned NMR, favourable 1H NMR spectra were 
difficult to obtain. These products include 7 (with CILs 1, 2R, and 3R), 8 (with CILs 1 and 2R), 
9 (with CIL 2R), 10 (with CIL 1), 11 (with CILs 1 and 2R) and 15 (with CIL 2R). These 
products could not be characterized via 1H NMR spectroscopy due to weak signals in their 
spectra. As their GC retention times, MS, and IR data matched their corresponding products 




3.2.3 Future work 
Photochemical [2+2] cycloadditions show promising results for optically active 
compounds induced by chiral ionic liquids. Future work would include fully completing Table 5 
with each CIL to get a better understanding on how they may impose enantioselectivity on the 
products, as well as repeating the reactions a few times to achieve replicable results.  
 Further, 1H NMR must be repeated on the products that were not fully characterized. 
Also, 13C NMR must be completed on all products to get a more accurate confirmation on the 
structure of each product. 13C NMR was not completed as the NMR instrument available 
exhibited numerous problems with the shimming and obtaining spectra with a good signal-to-
noise ratio. This NMR instrument will soon to be decommissioned as a new one was purchased, 
but due to the pandemic, it has not been installed yet. 
As well, GC with a chiral column should be additionally used to characterize each 
reaction product. As mentioned above, photochemical [2+2] cycloadditions have potential to 
produce up to 8 enantiomeric pairs if the alkene and the enone are both substituted. This method 
would be a very important step to analyze and provide more accurate information on any 
enantiomeric pairs found it the samples, and in turn, the specific rotations.  
Furthermore, the reusability of each CIL needs to be investigated to see how many times 
they can be reused and remain effective for in these specific reaction conditions. This can be 
completed by extracting the CIL and then measuring its own optical rotation and the products 
optical rotation. Next, it will be reused in the same reaction and the process will be repeated. As 
long as there is no significant change between the specific rotations of the product and CIL itself, 
it is still effective and may be reused again. 
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In conclusion, enhanced optical activity was seen when switching from an achiral 
environment using dichloromethane as the solvent to the chiral environment using the CILs as 
the solvent. More research must be completed on CILs to see whether they can impart 
enantioselectivity on these reactions as they show very promising potential. The photochemical 
[2+2] addition is a powerful reaction for synthetic chemists and controlling chirality in these 
reactions would make them an even better synthetic tool.  
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Chapter Four: Asymmetric Aldol Reaction 
4.1 Introduction    
The aldol reaction is one of the most effective and versatile methods for the formation of 
new carbon-carbon bonds in organic synthesis. [32] This reaction occurs between two 
aldehydes/ketones in which they react through an enolate or enol to produce a 𝛽-hydroxy 
carbonyl. The reaction proceeds as a self-condensation reaction when the enolate of the 
aldehyde/ketone attacks a molecule of the same un-enolized aldehyde/ketone to give the product. 
The aldol reaction is a reversible and is performed by either using acid or base catalysis. When 
the reaction is performed between two molecules of the same aldehyde, the equilibrium of the 
reaction lies to the right and is generally successful. On the other hand, when performed between 
two molecules of the same ketone, the equilibrium lies to the left and unsatisfactory yields may 
be achieved. [32] 
The aldol reaction has the potential to produce up to two new chiral centers and thus, two 
diastereomeric pairs of enantiomers may be formed. This presents numerous challenges in 
controlling regio-, diastereo-, and stereocontrol. If there is no effective form of chiral induction, 
then the enantiomers will be obtained as a racemic mixture. [33] 
The formation of new carbon-carbon bonds with complete stereocontrol is of great 
importance in organic synthesis. The aldol reaction is one of the most powerful transformations 
in organic synthesis and the products of these reactions may be used for the preparation of key 
intermediates in the synthesis of important and complex natural products. Further, the carbonyl 
and hydroxyl groups generated by the aldol reaction can be converted selectively to other 
functional groups. Asymmetric aldol reactions produce chiral 𝛽-hydroxy carbonyl systems that 
serve as building blocks for antibiotics as well as precursors for antihypertensive drugs and 
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calcium antagonists. Current methods to control chirality in these reactions include the use of a 
chiral catalyst paired with an organic solvent. Although proven effective, organic solvents are 
volatile and pose negative health and environmental effects, and thus, alternative methods need 
to be researched. There are a handful of examples in the literature in which CILs have worked 
successfully to induce enantioselectivity in aldol reactions and thus they may provide a green, 
effective alternative to current approaches. [34] 
  The first direct enantioselective aldol reaction of an aldehyde was presented by Northrup 
and MacMillan in 2002. The researchers used an L-proline based catalyst and a variety of 
different aldehydes and the solvent dimethylformamide (DMF). Using these reaction conditions, 
they were able to achieve good yields (80%) and high levels of enantiocontrol (99% ee). The 
relationship between the two chiral centers is 4:1 anti:syn. [35] 
 
Scheme 13. Enantioselective aldol reaction using a L-proline based catalyst. 
 There are a series of publications by Lombardo et al. that presented a handful of cross-
aldol reactions in chiral ionic liquids with excellent enantioselectivies (>99% ee) and good yields 
(80-90%). They used an L-proline based CILs to induce enantioselectivity in their reactions and 
as the base to catalyze the reaction. Their reactions had no organic solvent but contained water 
and excess amounts of the ketone, which acted as the nucleophile. The diastereoselectivies were 





Scheme 14. Enantioselective cross-aldol reactions using a CIL. 
The first counter anion they used for their chiral cation in their IL was BF4
- where they achieved 
results of 64% yield and 85% enantiomeric excess.  They later observed a higher efficiency with 
the lipophilic bis(trifluoromethylsulfonyl)imide (NTf2
-) counter anion. Here, they achieved 
yields of 37% and enantiomeric excess greater than 99%. Another improvement was made when 
they used aqueous biphasic conditions instead of only the CIL alone as the solvent. Further, 
another advancement was observed when they switched from using trans-geometry to cis-
geometry of the imidazolium 4-hydroxyproline ionic moiety. This improved the product yield 
from 37% to 87%. [10] 
Aldol reactions are extremely important for synthetic organic chemists as they provide an 
effective method for the formation of new carbon-carbon bonds. These reactions are regularly 
used to construct the carbon frameworks of complex biologically active compounds that contain 
many stereocenters. Controlling enantioselectivity in these reactions with an effective green 
approach is integral and the use of CILs to do so must be explored. 
4.2 Results & Discussion 
4.2.1 Aldol Reactions 
 Twelve aldol reactions have been performed in an achiral environment using the 
traditional organic solvent, DMF. A variety of different aldehydes and ketones have been chosen 
for use. Each of these reagents were reacted separately with two bases, morpholine and 
pyrrolidine. The structures of the reagents are as follows: 
 29 
 
Figure 8. The name and structure of the various aldehydes and ketones used. 
 
Figure 9. The structure of morpholine and pyrrolidine. 
DMF was chosen as the solvent as the procedure was derived from the research completed by 
Northrup and MacMillan, “The first Direct Enantioselective Cross-aldol Reaction of Aldehydes”. 
[35] The researchers experimented with a variety of different solvents and noted that the best 











Figure 10. The name and structure of each aldol addition product. 
These reactions were completed successfully. Each reaction was characterized via gas 
chromatography (GC), infrared (IR) spectrometry, mass spectrometry (MS), 1H NMR 
spectroscopy and compared to the literature values. The exceptions are products 20 and 21 that 
could not be characterized via 1H NMR. Compound 20A was produced in an unpurified yield of 
about 3.2% which amounted to 10.5 mg. This reaction was repeated 3 times and each time 
produced a similar low yield. This amount of material was too low for purification and thus, no 
characterization at all was completed. However, its GC retention time was compared to 
compound 20 when completed in the CILs and they were the same. Thus, it was assumed that the 
correct product was synthesized. Further, products 19A, 20B, 21A and 21B gave yields of 11.4 
mg (2.7%), 8.9 mg (2.5%), 31.5 mg (7.4%), and 16.3 mg (3.8%), respectively. These are very 
low and in combination with the soon to be decommissioned NMR instrument, no useable NMR 
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spectra were produced. The spectra had very weak signals and thus, these products could not be 
characterized. As their GC retention times, MS, and IR data matched their corresponding 
products completed in the chiral environment, they are assumed to be successfully synthesized.  
Additionally, the specific rotations of each reaction were taken to ensure that they were 
not optically active as they were completed in an achiral environment. The specific rotations are 
presented in Table 6. 
Table 6.  Specific rotations of each aldol reaction product obtained using DMF as the solvent. 
 
Entry Product Base Used Specific Rotations 
1 16 A -1.48 ± 1.24 
2 B -1.36 ± 1.42 
3 17 A -0.249 ± 0.251 
4 B 0 ± 0 
5 18 A 0 ± 0 
6 B -0.38 ± 0.383 
7 19 A 0 ± 0 
8 B -1.77 ± 1.47 
9 20 A No product isolated 
10 B 0 ± 0 
11 21 
 
A 0 ± 0 
12 B 0 ± 0 
A: Reaction was completed using morpholine as the base. 
B: Reaction was completed using pyrrolidine as the base. 
 
Again, using error analysis by taking into consideration the error associated with the polarimeter, 
volumetric flask, and balance, most of the specific rotations can be seen as 0. The exceptions are 
products 16A and 19B, and their specific rotations after taking error analysis into account are 
0.24 and 0.30, respectively. These values are extremely close to zero and should be assumed to 
have no optical activity. 
In conclusion, this confirms that every reaction completed in the achiral environment is 
not optically active and in turn, guarantees that any degree of rotation exhibited by the reactions 
completed in the CILs is a result of the chiral environment. 
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4.2.2 Asymmetric Aldol Reactions 
 Twenty-two aldol reactions have been completed using seven different CILs as solvents 
to induce enantioselectivity. The same combination of reagents from the aldol reactions in the 
achiral environment using DMF were used. All reactions were completed with 1-butyl-3-
methylimidazolium S-camphorsulfonate (2S). Two additional reactions were completed with 1-
butyl-3-methylimidazolium R-camphorsulfonate (2R), 1-butyl-3-menthoxymethylimidazolium 
bis(trifluoromethanesulfonyl)amide (4), 1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-
imidazolium bromide (5), and 1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide 
(6). One additional reaction with both R-2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate (3R) and S-2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate (3S) were completed. The reaction done with 3S was 
supposed to be completed with the R-enantiomer but as the starting material for the R-
enantiomer ran out, 3S was synthesized for use. The specific rotations and associated error of the 










Table 7.  Specific rotations of each aldol reaction product obtained using seven CILs as the 
solvents. 
 CIL 
Entry Product  2R 2S 3R 3S 4 5 6 

























3 17 A -  -3.01 
± 0.623 
- - - - - 
4 B - -6.42 
± 1.96 
- - - - - 
5 18 
 
A - -6.06 
± 1.61 
- - - - - 
6 B - -3.49 
± 1.21 
- - - - - 
7 19 A - -9.74 
± 1.56 
- - - - - 
8 B - -1.85 
± 0.769 
- - - - - 
9 20 A - No 
yield 
- - - - - 
10 B - -3.00 
± 1.06 
- - - - - 
11 21 
 
A - -4.77 
± 1.58 
- - - - - 
12 B - -1.38  
± 0.569 
- - - - - 
A: Reaction was completed using morpholine as the base. 
B: Reaction was completed using pyrrolidine as the base. 
 
 Comparing these specific rotations to the aldol additions completed in the achiral 
environment, enhanced optical activity is seen. Similar to the photochemical [2+2] 
cycloadditions, all CILs used in the aldol reactions with the exception of 1-butyl-3-
menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4) yielded products with 
negative specific rotations. Again, both R- and S- enantiomers of 1-butyl-3-methylimidazolium 
camphorsulfonate (2R, 2S) and 2-amino-N,N,N-trimethyl-1-butanol-
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bis(trifluoromethanesulfon)imidate (3R, 3S) yielded products with negative specific rotations. 
Both 1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (5) and 1-butyl-3-
[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide (6) have positive specific rotations and 
yielded products with negative specific rotations. It is important to note that this provides 
additional evidence the CIL is fully removed from the product and any optical activity displayed 
does not come from residual CIL as S-enantiomers produced products with negative rotations. 
Further, 1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4) has a 
positive literature specific rotation and also yielded products with a positive specific rotation. 
The magnitude of rotation exhibited in product 16B is significantly larger than the CILs rotation 
and thus, this further confirms that the optical activity displayed is not solely from any residual 
CIL. 
Again, there is no specific trend that can be seen between the CILs and the specific 
rotations. A few single reactions that can be highlighted include when 1-butyl-3-
methylimidazolium S-camphorsulfonate (2S) was used in conjunction with morpholine to impart 
enantioselectivity on the product 19A. The specific rotation of this product is -9.74 ± 1.56. As 
well, when 1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide (4) was 
used in conjunction with morpholine and pyrroldine to impart enantioselectivity on the product 
16A and 16B. The specific rotation of both products are 32.42 ± 1.03 and 85.99 ± 0.931, 
respectively. CIL 4 consistently gave products a specific rotation with a larger magnitude. For 
more reliable data, these reactions should be repeated. These replicate reactions were not 
completed due to time constraints. Replication would allow for better visualization of any 
patterns or general trends that exists between the CILs used and the optical activity of the 
products. 
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Using the optical rotations found in the literature, [35] it was possible to determine ee 
values for product 16 (entries 1 and 2, Table 7). The researchers used a GC with a chiral column 
to analyze their product which gave a reported specific rotation of [α]D = -14.7 (2S, 3S)-3-
hydroxy-2-methylpentanal and a calculated enantiomeric excess of 99%. The specific rotations 
for CIL 4 are well above the specific rotations for the pure enantiomer given in the literature and 
therefore, this data needs to be verified through repeating experiments. With those entries not 
being taken into consideration (CIL 4), the reactions resulted in the preparation of 3-hydroxy-2-
methylpentanal with ee of 9-35% with pyrrolidine as the base. Based on their assignment and our 
negative rotations we assign the product to be (2S, 3S)-3-hydroxy-2-methylpentanal. 
 
Figure 11. The product (2S, 3S)-3-hydroxy-2-methylpentanal. 
 Looking at the effect of CILs 5 and 6 in Table 7 (entries 1 and 2), it is evident that they 
produced products with a smaller magnitude of optical activity compared to the other CILs. Both 
CILs 5 and 6 have a small magnitude of rotation, with literature values of 1.4 and 2.2, 
respectively. Therefore, it is reasonable that the magnitude of enantioselectivity imparted on 
these products is small. In contrast, CIL 4 has a literature rotation of 54.0, and it can be seen in 
Table 7 (entries 1 and 2), that it imparted a larger magnitude of enantioselectivity on these 
products. With the few reactions completed, it is plausible that the magnitude of 
enantioselectivity imposed on the products may be related to the degree in which the chiral 
center of the CIL impacts the overall optical activity of the liquid. 
Again, due to time constraints, the enantiopurity of each product was not measured. In 
asymmetric aldol reactions, up to two new chiral centers can be formed. This has the potential to 
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produce 2 enantiomeric pairs. GC with a chiral column would be an accurate method to 
distinguish if the product contains enantiomers. Enantiomers rotate plane-polarized light in equal 
and opposite directions. If any product contains an unequal mixture of enantiomers, this will 
affect the magnitude of the optical rotation. Therefore, although some of the specific rotations 
appear to have a small magnitude, this may be due to the product containing an enantiomeric pair 
in unequal concentrations. Moreover, if a product has a large magnitude of rotation, it may be 
due to the reaction greatly favouring one enantiomer over the other. Furthermore, it is recognized 
that diastereomeric pairs are formed in aldol reactions and until GC with the chiral column is 
complete, it is unknown what ratio of the four diastereomeric products we have. 
 The mechanism of the aldol reaction can occur through a base-catalyzed or enamine-
forming amine mechanism. The mechanism of the base-catalyzed reaction begins with the base 
removing a 𝛼-hydrogen of the carbonyl to form an enolate that will attack the second molecule 
of the carbonyl. This results in an ionic species that will then remove a proton from the 
protonated base to form the product.  
 
Scheme 15. Base catalyzed aldol reaction mechanism. 
In the enamine-forming amine mechanism the 2° amine will react with the aldehyde/ ketone to 
form an enamine. Next, the enamine performs a nucleophilic attack to form an iminium, 
followed by hydrolysis to reform the carbonyl. 
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Scheme 16. Enamine forming amine aldol reaction mechanism. 
It was evident that the aldol reactions were proceeding via the enamine mechanism after 
characterization. MS showed that we were not able to remove the enamine as there were no M+ 
peaks corresponding to the desired product but fragment peaks that corresponded to the mass of 
the product with the enamine attached. IR confirmed this as well by displaying N-H stretching in 
the amine frequency range. The workup for the aldol reactions completed in the CILs involved 
first the removal of the CIL through extraction with a non-polar organic solvent and second the 
use of a SPE silica gel filter to ensure any residual CIL was removed. The original reactions 
completed in the achiral environment included a work-up that used water and brine. After 
realizing that the enamine was still attached, this work-up was applied to the reactions performed 
in the CILs. This resulted in removing the enamine through hydrolysis in most aldol products. 
The exceptions were with the reactions completed with propanal. Unfortunately, the enamine 
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could not be fully removed via hydrolysis as MS still displayed fragment peaks corresponding to 
the mass of the product with the enamine still attached.  
 
Figure 12. The product 3-hydroxy-2-methylpentanal with the enamine attached. 
Although, after hydrolysis for most of the propanal products, 1H NMR spectroscopy produced 
spectra that corresponded to the correct aldol product (3-hydroxy-2-methylpentanal, 16). Thus, it 
is evident that there is a mixture of the correct aldol product and product with the enamine still 
attached. The exceptions are 16A completed in CIL 3R and 16B completed in CIL 1 in which the 
product only contained the attached enamine. It is important to note that in the case of a mixture 
of the correct product and the product with the enamine attached, the reported MS corresponds to 
possible fragments of the enamine product. This includes product 16A (completed in CILs 2R, 
2S, 3R, 5 and 6) and 16B (completed in CILs 2R, 2S, 3S, 4, 6). Product 16A (completed in CIL 
4) in the only product in which the enamine was successfully removed after hydrolysis. 
 With the mechanism of the aldol reaction in mind, there is a possibility of two different 
enamines to form with each product as two structurally different bases were used. For the CIL to 
impart chirality onto the product, it will interact with molecules of itself and possibly other 
reagents to form a chiral pocket that the product will fit into. With a structurally different base, it 
is possible that this will affect the optical activity of the products. Comparing the specific 
rotations of the same product when different bases are used, no evident difference is seen in most 
cases.  
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 After column chromatography, few products were collected in very low yields and in 
combination with the soon to be decommissioned NMR, reliable 1H NMR spectra could not be 
obtained. These products include 16B (with CIL 6) and 18B (with CIL 2S). These products could 
not be characterized via 1H NMR spectroscopy due to weak signals in their spectra. As their GC 
retention times, MS, and IR data matched their corresponding products completed in the achiral 
environment, they are assumed to be successfully synthesized.  
4.2.3 Future Work 
 Aldol reactions show promising results for optically active compounds induced by CILs. 
Future work would include fully completing Table 7 with each CIL to get a better understanding 
on how these CILs may impose enantioselectivity on the products. As well as repeating each 
reaction a few times to ensure reproducible results. 
Further, 1H NMR must be repeated on the products that could not be fully characterized. 
Also, 13C NMR must be completed on all products to get a more accurate confirmation on the 
structure of each product. Furthermore, GC with a chiral column should additionally be used to 
characterize each reaction product. As mentioned above, the aldol reaction has the potential to 
produce two enantiomeric pairs and this method would be an important step to analyze and 
provide more accurate information on any enantiomeric pairs found in the samples, and in turn, 
their specific rotations. Furthermore, the reusability of each CIL needs to be investigated to see 
how many times they can be reused and remain effective for in these specific reaction conditions.  
 In conclusion, enhanced optical activity was demonstrated when switching from the 
achiral environment using DMF as the solvent to the chiral environment using the CILs as the 
solvent. More research must be completed on using CILs to induce enantioselectivity in aldol 
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reactions as they show a very promising alternative to harmful traditional organic solvents paired 























Chapter 5: Experimental 
5.1 Experimental 
5.1.1 General Experimental Techniques, Instrumentations and Materials 
Analytical gas chromatography was performed on a Hewlett Packard 5890 equipped with 
a flame ionization detector (FID) using a 30 m by 0.25 mm DB-5HT capillary column of (5% 
phenyl)methylpolysiloxane. There was a flow rate of 2.0 mL/min with the carrier gas nitrogen 
and a column pressure of 21 psi. The instrument was programmed at: initial temperature = 80 °C, 
initial time = 2.0 minutes, rate = 8.0 °C/minute final temp = 150 °C, final time = 3 minutes.  
Analytical thin layer column chromatography (TLC) was performed on TLC Silica gel 60 
F254 with a thickness of 175-225 μm. The TLC plates are visualized using a handheld UV lamp 
and stained with p-anisaldehyde followed by heating with a heat gun. Column chromatography 
was used to purify products using a 230-400 mesh silica gel with a particle size of 40-63 𝜇m. 
The solvent system for the column consisted of varying concentrations of hexanes and ethyl 
acetate using a gradient technique.  
All photochemical reactions were performed using an immersion 7825 mercury-vapour 
lamp purchased from Hanovia. Each photochemical reaction was run for 24 hours.  
Optical rotations were measured on a Perkin Elmer Model 343 polarimeter with a sodium 
spectral lamp 93 122E and a 1 dm cell. All measurements were taken at room temperature. All 
samples were diluted with dichloromethane unless otherwise noted. All specific rotation 
concentrations are reported in g/100 mL.  
Infrared (IR) spectra were measured on a Perkin Elmer 1320 IR Spectrometer with a 
resolution of 1 cm-1. All spectra were determined without solvent (neat) in the transmission mode 
using KBr and are reported as wavenumbers.  
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Mass spectra (MS) were measured on an Advion Expression-L CMS using atmospheric-
pressure chemical ionization (APCI). All spectra were determined without solvent (neat) using a 
direct Atmospheric Solids Analysis Probe (ASAP). 
 Proton nuclear magnetic resonance (1H NMR) spectra were measured on a Varian AS500 
using the UNITYINOVA NMR spectrometer system, VNMR 6.1C software at room 
temperature. The solvent used was CDCl3. Chemical shifts are reported in parts per million 
(ppm) from an internal standard of tetramethylsilane (TMS). The NMR data are reported as 
follows: chemical shift multiplicity, coupling constant in Hertz, integration). Carbon nuclear 
magnetic resonance (13C NMR) spectra were also recorded at 125 MHz using CDCl3 as the 
solvent. 
 Each reaction was run under nitrogen in flasks that were oven or flame dried. Reagents 
were transferred using a syringe and introduced into the flask though a rubber septum. Excess 
water was removed from the organic extracts using the drying agent anhydrous magnesium 
sulfate (MgSO4), and then filtered by gravity. Excess solvents were removed from the flask using 
a Buchi rotatory evaporator under reduced pressure obtained by the water aspirator. 
Dimethylformamide (DMF) was dried by storing over molecular sieves. All other solvents were 
used as received. All chemicals for which procedures are not listed were purchased from Sigma 
Aldrich. 
5.2 Preparations 
5.2.1 Experimental for Chapter Two 
General Procedure for the Synthesis of 1-butyl-3-methylimidazolium L-Lactate (1) 
Equimolar amounts 1-butyl-3-methylimidazolium chloride (8.8 mmol, 1.54 g) and 
sodium (L)-lactate (8.8 mmol, 0.99 g) were combined in a heavy wall flask with a small amount 
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of acetone (2.5 mL). The flask was degassed with nitrogen for 30 seconds. The sealed mixture 
was heated to 50°C in an oil bath for approximately 24 hours. The liquid was filtered by vacuum 
to remove the salt. Excess solvent was removed using the rotatory evaporator to result in 1.82 g 
(90%) of the chiral ionic liquid.  
[𝛼]: -5.09 ( c = 1.06, dichloromethane); IR(neat) νmax (cm-1): 3712.25, 3480.7, 2967.9, 2938.7, 
2877.6, 1718.1; MS m/z: [M+H]+ calculated for C8H15N2: 139.12, found 139.1. [M-H]
- 
calculated for C3H5O3
-: 89.03, found 89.1. 
General Procedure for the Synthesis of 1-butyl-3-methylimidazolium Camphorsulfonate (2R, 2S) 
Equimolar amounts of 1-butyl-3-methylimidazolium chloride (10.2 mmol, 1.78 g) and 
(1S)- or (1R)-10- camphorsulfonic acid (10.2 mmol, 2.37 g) were combined in a heavy wall flask 
with a small amount of acetone (2.5 mL). The flask was degassed with nitrogen for 30 seconds. 
The mixture was heated to 50°C in an oil bath for approximately 24 hours. Excess solvent was 
removed using the rotatory evaporator to result in 3.77 g (>99%) of the R-enantiomer and 3.47 g 
(94%) of the S-enantiomer. 
R-enantiomer: [𝛼]: -20.24 (c = 0.420, dichloromethane); IR(neat) νmax (cm-1): 3460, 3149, 3103, 
2960, 1741, 1374; MS m/z: [M+H]+ calculated for C8H15N2: 139.12, found 139.1. [M+2]
+ 
calculated for C10H15O4S + 2H: 233.08, found 233.1. 
S-enantiomer: [𝛼]: 19.71 (c = 0.695, dichloromethane); IR(neat) νmax (cm-1): 3462, 3148, 3102, 
2961, 1739, 1374; MS m/z: [M+H]+ calculated for C8H15N2: 139.12, found 139.2. [M+2]
+ 




General Procedure for the Synthesis of 2-amino-N,N,N-trimethyl-1-butanol-
bis(trifluoromethanesulfon)imidate  (3R, 3S) 
 (R)- or (S)-2-amino-1-butanol (1 mmol, 89.1 mg) was dissolved in dichloromethane (10 
mL) and Me2SO4 (1 mmol, 126 mg) was added dropwise (30 minutes). The solvent was removed 
by a rotatory evaporator. The residue was dissolved in water (2 mL). Addition of N-
lithiotrifluoromethanesulfonimide (1.1 mmol, 315 mg) in water (1 mL) led to the preparation of 
the product. The product was washed with water (3 x 5 mL) and dried under vacuum at 100℃ (5 
hrs) to give 0.156 g (37%) of the R-enantiomer and 0.144 (35%) of the S-enantiomer. 
R-enantiomer: [𝛼]: -9.36 (c = 0.114, methanol); IR(neat) νmax (cm-1): 3537, 3176, 2982, 2891, 
1196, 1058; MS m/z: [M+H]+ calculated for C7H18NO
+ + H: 132.14, found: 131.9. [M-H]- 
calculated for C2F6NO4S2
-: 279.9, found 279.8. 
S-enantiomer: [𝛼]: 7.80 (c = 0.141, methanol); IR(neat) νmax (cm-1): 3507, 3170, 2982, 2894, 1190, 
1052; MS m/z: [M+H]+ calculated for C7H18NO
+ + H: 132.14, found: 131.9. [M-H]- calculated for 
C2F6NO4S2
-: 279.9, found 279.8. 
General Procedure for the Synthesis of 
1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide[22] (4) 
 (+)-Chloromethyl menthyl ether (12.2 mmol, 2.50 g) was added dropwise over 30 minutes 
to a vigorously stirred solution of 1-butylimidazole (12.2 mmol, 1.51 g) in dry hexanes (15 mL) in 
a 3-neck round bottom flask equipped with a stir bar and reflux condenser that was capped with a 
nitrogen filled balloon. The mixture was stirred for 30 minutes at room temperature and then 
evaporated to dryness on the rotatory evaporator. The resulting white powder was dissolved in 
distilled water (50 mL). N-lithiotrifluoromethanesulfonimide (12.2 mmol, 3.5 g) was added. The 
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solution was washed with water (3 x 15mL). The final product was heated under pressure (100℃) 
to remove water to give 4.35 g (62%) of the chiral ionic liquid. 
[𝛼]: 53.43 (c = 0.812, dichloromethane); IR(neat) νmax (cm-1): 3146, 3085, 2961, 2874, 1459, 1354, 
1201, 1138; MS m/z: [M+H]+ calculated for C18H33N2O
+: 293.25, found 292.2. [M-H]- calculated 
for C2F6NO4S2
-: 279.9, found 279.8. 
General Procedure for the Synthesis of (S)-citronellyl bromide 
In a round bottom flask triphenyl phosphine (19.2 mmol, 5.036 g), imidazole (19.2 mmol, 
1.307 g) and bromine (19.2 mmol, 0.983 mL) were combined with anhydrous dichloromethane 
(75.0 mL). S-(-)-citronellol (16 mmol, 2.92 mL) in anhydrous dichloromethane (5 mL) was added 
to the stirring solution. The flask was back filled with nitrogen and to stirred for 3.0 hrs at room 
temperature, then concentrated. Flash column chromatography (90% hexanes, 10% ethyl acetate) 
yielded the 2.4614 g (71%) product as a clear liquid. 
IR (neat) νmax (cm
-1): 2965, 2923, 1451 and 1378; 1H NMR (500 MHz, CDCl3) δ (ppm): 5.10 (1H, 
t, J = 7.0 Hz), 3.43 (2H, m), 1.99 (2H, m), 1.89 (1H, m), 1.70 (3H,s), 1.62 (3H, s), 1.35 (2H, m), 
1.20 (2H, m), 0.913 (3H, d, J = 6.0 Hz); MS m/z: [M+H]+ calculated for C10H19Br + H: 220.065, 
found 220.0.   
General Procedure of 1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide (5) 
Equimolar amounts of S-citronellyl bromide (14 mmol, 1.1494 g, 1.12 mL) and 1-
methylimidazole (14 mmol, 3.0682 g) were combined into a heavy wall flask filled with nitrogen, 
sealed and heated at 40 ℃ for 5 days. The product was dried under vacuum at 40 ℃ for 2 days to 
give 3.0689 g (90%) of the product as a light brown viscous oil. 
[𝛼]: 1.29 (c = 0.459 M, dichloromethane) 
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General Procedure of 1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide (6) 
Equimolar amounts of S-citronellyl bromide (14 mmol, 3.0682 g) and 1-butylimidazole 
(14 mmol, 1.1739, 1.84 mL) were combined into a heavy wall flask filled with nitrogen, sealed 
and heated at 40 ℃ for 5 days. The product was dried under vacuum at 40 ℃ for 2 days to give 
2.6612 g (83%) of the product as a light brown viscous oil. 
[𝛼]: 2.21 (c = 0.473 M, dichloromethane) 
5.2.2 Experimental for Chapter Three 
General Method for Achiral Reactions 
 The alkene (15 equivalents) and the enone (1 equivalent) were dissolved in CH2Cl2 (2 
mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 hours. Excess solvent was 
removed by the rotatory evaporator to result in the product. 
Tricyclo[5.3.0.02,6]decan-3-one (7) 
2-Cyclopentenone (0.08 mL, 1 mmol) and cyclopentene (1.32 mL, 15 mmol) were 
dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 24.5 mg (17.1 %) of 
the product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2922.7, 2849.4, 1703.9; MS m/z: 148.9, 123.0, 81.0. [M+H]+ calculated for 
C10H14O + H: 151.11, found 151.0; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.22 (1H, m), 1.90 
(1H, m), 1.67 (1H, m), 1.56 (1H, m), 1.56 (1H, m), 1.43 (1H, m), 1.38 (1H, m), 1.31 (1H, m), 






2-Cyclopentenone (0.08mL, 1 mmol) and cyclohexene (1.52 mL, 15 mmol) were 
dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 36.7 mg (22%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2926.8, 2854.6, 1729.3; MS m/z: 149.1, 137.0 [M+H]+ calculated for 
C11H16O + H: 165.13, found 165.9; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.95 (1H, m), 2.81 (1H, 
m), 2.72 (1H, m), 2.69 (1H, m), 2.59 (1H, m), 2.45 (1H, m), 2.24 (1H, m), 2.23 (1H, m), 2.06 
(1H, m), 1.90 (1H, m), 1.82 (1H, m), 1.74 (1H, m), 1.63 (1H, m), 1.45 (1H, m), 1.37 (1H, m), 
1.25 (1H, m); [𝛼]: -1.55 ± 1.56 (c = 0.058, dichloromethane) 
Tricyclo[6.3.0.02,7]undecan-3-one (9) 
2-Cyclohexenone (0.097 mL, 1 mmol) and cyclopentene (1.32 mL, 15 mmol) were 
dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 29.3 mg (17.8%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2940.4, 2862.3, 1702.1; MS m/z: 148.9, 97.0 [M+H]+ calculated for 
C11H16O + H: 165.13, found 164.9; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.65 (1H, m), 2.45 
(1H, m), 2.29 (1H, m), 2.20 (1H, m), 2.15 (1H, m), 1.80 (1H, m), 1.77 (1H, m), 1.75 (1H, m), 
1.72 (1H, m), 1.60 (1H, m), 1.58 (1H, m), 1.40 (1H, m), 1.38 (1H, m), 1.24 (2H, m), 0.92 (1H, 
m); [𝛼]: -0.40 ± 2.40 (c = 0.249, dichloromethane) 
Tricyclo[6.4.0.02,7]dodecan-3-one (10) 
2-Cylohehexenone (0.097 mL, 1 mmol) and cyclohexene (1.52 mL, 15 mmol) were 
dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
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hours. Excess solvent was removed via rotatory evaporator to result in 39.9 mg (22.4%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2931.7, 2854.1, 1701.6; MS m/z: 162.9,148.9 [M+H]+ calculated for 
C12H18O + H: 179.14, found 178.9; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.41 (1H, m), 2.31 
(1H, m), 2.25 (1H, m), 2.19 (1H, m), 2.07 (1H, t, J = 4.6), 1.92 (1H, m), 1.84 (1H, m), 1.76 (2H, 
m), 1.64 (1H, m), 1.60 (1H, m), 1.59 (1H, m), 1.54 (1H, m), 1.52 (1H, m), 1.46 (1H, m), 1.39 
(1H, m), 1.31 (2H, m); [𝛼]: -0.17 ± 0.341 (c = 0.287, dichloromethane) 
7,7-Dichlorobicyclo[4.2.0]octan-2-one (11) 
2-Cyclohexenone (0.097 mL, 1 mmol) and 1,1-Dichloroethylene (1.2 mL, 15 mmol) were 
dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed via rotatory evaporator to result in 51.3 mg (28.6%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 3056.6, 2918.9, 2871.1, 2848.5, 1705.8, 736.6, 702.9; MS m/z: 156.9, 
148.9, 174.9 [M+H]+ calculated for C8H12Cl2 + H: 192.01, found 192.9; 
1H NMR(500 MHz, 
CDCl3) δ (ppm): 3.20 (1H, m), 3.12 (1H, d, J = 8.0), 3.04 (1H, m), 2.81 (1H, m), 2.67 (1H, t, J = 
7.5), 2.38 (1H, t, J = 3.5), 2.27 (1H, m), 1.99 (1H, m), 1.87 (1H, m), 1.70 (1H, m), 1.52 (1H, t), 
1.49 (1H, t);  [𝛼]: -3.47 ± 3.71(c = 0.144, dichloromethane) 
6-Methyltricyclo[5.3.0.02,6]decan-3-one (12) 
3-Methyl-2-cyclopentenone (0.1 mL, 1 mmol) and cyclopentene (1.32 mL, 15 mmol) 
were dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 15.2 mg (9.3%) of the 
product after purification by column chromatography. Product determined by comparing its GC 
retention time to compound 12 completed in the CILs. 
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IR(neat) νmax (cm
-1): 2947.7, 2860.5, 1734.6; MS m/z: 149.1, 137.1, 121.1 [M+H]+ calculated for 
C11H16O + H: 165.13, found 165.9;  
1H NMR(500 MHz, CDCl3) δ (ppm): 2.68 (1H, m), 2.50 
(1H, m), 2.25 (1H, m), 1.99 (1H, m), 1.82 (1H, m), 1.78 (1H, m), 1.71 (1H, m), 1.69 (1H, m), 
1.67 (1H, m), 1.63 (1H, m), 1.60 (1H, m), 1.40 (1H, m), 1.32 (1H, m), 0.94 (3H, s); [𝛼]: 0 ± 0 (c 
= 0.151, dichloromethane) 
6-Methyltricyclo[5.4.0.02,6]undecan-3-one (13) 
3-Methyl-2-cyclopentenone (0.1 mL, 1 mmol) and cyclohexene (1.52 mL, 15 mmol) 
were dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 41.5 mg (23.2%) of the 
product. 
IR(neat) νmax (cm
-1): 2928.1, 2857.5, 1729.0; MS m/z: 149.8, 135.0, 81.0 [M+H]+ calculated for 
C12H18O + H: 179.14, found 178.9.; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.62 (1H, m), 2.50 
(1H, m), 2.44 (1H, m), 2.23 (1H, m), 2.05 (1H, m), 1.97 (1H, m), 1.85 (1H, m), 1.79 (1H, m), 
1.68 (1H, m), 1.63 (1H, m), 1.58 (1H, m), 1.51 (1H, m), 1.41(1H, m), 1.33 (1H, m), 1.31 (1H, 
m),  0.97 (3H, s); [𝛼]: -1.01 ± 0.997 (c = 0.089, dichloromethane) 
7-Methyltricyclo[6.4.0.02,7]undecan-3-one (14) 
3-Methyl-2-cyclohexenone (0.11 mL, 1 mmol) and cyclopentene (1.32 mL. 15 mmol) 
were dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 104 mg (58.3%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2947.5, 2864.1, 1718.7; MS m/z: 149.9, 121.1, 93.1, 81.0  [M+H]+ 
calculated for C12H18O + H: 179.14, found 178.9; 
1H NMR(500 MHz, CDCl3) δ (ppm): 3.16 
(1H, d, J = 3.4 Hz), 2.69 (1H, dd, J = 8.7, 1.25), 2.51 (1H, m),  2.36 (1H, m), 2.19 (1H, m), 2.07 
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(2H, m), 1.94 (1H, m), 1.82 (2H, m), 1.67 (2H, m), 1.51 (1H, m),  1.43 (1H, m), 1.31 (1H, m), 
0.94 (3H, s); [𝛼]: -0.79 ± 0.80 (c = 0.502, dichloromethane) 
7-Methyltricyclo[6.4.0.02,7]dodecan-3-one (15) 
3-Methyl-2-cyclohexenone (0.11 mL, 1 mmol) and cyclohexene (1.52 mL, 15 mmol) 
were dissolved in CH2Cl2 (2 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 
hours. Excess solvent was removed by the rotatory evaporator to result in 80.3 mg (41.8%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2986.8, 2931.1, 1655.4; MS m/z: 165.7, 149.8, 81.0 [M+H]+ calculated for 
C13H20O + H: 193.16, found 193.5; 
1H NMR(500 MHz, CDCl3) δ (ppm): 2.49 (1H, m), 2.31 
(1H, td), 2.15 (1H, m), 2.10 (1H, m), 2.04 (1H, m), 1.83 (1H, m), 1.77 (1H, m), 1.72 (1H, m), 
1.68 (2H, m), 1.59 (1H, m), 1.51 (2H, m), 1.34 (2H, m), 1.32 (2H, m), 0.88 (3H, s); [𝛼]: -1.05 ± 
0.959 (c = 0.521, dichloromethane) 
General Method for Chiral Reactions 
 The alkene (15 equivalents) and the enone (1 equivalent) were added to the chiral ionic 
liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg lamp for 24 hours. Diethyl 
ether (5 × 1 mL) was added to the mixture to remove the organic component from the chiral 
ionic liquid. The organic mixture was injected through an SPE silica gel filter to remove any 
excess chiral ionic liquid. Excess solvent was removed by the rotatory evaporator to result in the 
product mixture which was purified by column chromatography. The CIL used for each case is 
listed followed by the characterization of the product. 
Tricyclo[5.3.0.02,6]decan-3-one (7) 
2-Cyclopentenone (0.04 mL, 0.5 mmol) and cyclopentene (0.66 mL, 7.5 mmol) were 
dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg 
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lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.00 (c = 0.349, dichloromethane) 
Product determined by comparing its GC retention time with product 7 completed in the 
achiral environment. 
Yield: 15.8 mg (10.5%); IR(neat) νmax (cm
-1): 2986.3, 2926.5, 2854.3, 1728.3; MS m/z: 
[M+H]+ calculated for C10H14O + H: 151.11, found 150.9; [𝛼] = -12.86 ± 3.06 (c = 
0.093, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = 17.99 (c = 0.478, dichloromethane) 
Product determined by comparing its GC retention time with product 7 completed in the 
achiral environment. 
Yield: 23.1 mg (22.6%); IR(neat) νmax (cm
-1):  2927.2, 2867.9, 1736.2; MS m/z: [M+H]+ 
calculated for C10H14O + H: 151.11, found 150.9; [𝛼] = -1.08 ± 0.442 (c = 0.462 M, 
dichloromethane) 
1-butyl-3-methylimidazolium S-camphorsulfonate: [𝛼] = 18.21 (c = 0.494, dichloromethane) 
Yield: 15.0 mg (10.5%); IR(neat) νmax (cm
-1): 2928.1, 2865.1, 1734.2; MS m/z: 123.4 
[M+H]+ calculated for C10H14O + H: 151.11, found 151.8; 
1H NMR (500 MHz, CDCl3) δ 
(ppm): 2.22 (1H, m), 2.17 (1H, m), 2.04 (1H, m), 1.93 (1H, m), 1.67 (1H, m), 1.56 (1H, 
m), 1.51 (1H, m), 1.41 (1H, m), 1.38 (1H, m), 1.30 (2H, m), 1.15 (1H, m), 0.96 (1H, m), 
0.82 (1H, m); [𝛼] = -1.21 ± 0.419 (c = 0.352, dichloromethane) 
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R-2-amino-N,N,N-trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate: [𝛼] = -8.33 (c = 0.108 
M, dichloromethane) 
Product determined by comparing its GC retention time with product 7 completed in the 
achiral environment. 
Yield: 20.1 mg (13.4%); IR(neat) νmax (cm
-1): 2960.1, 2924.3, 2850.9, 1733.66; MS m/z: 
[M+H]+ calculated for C10H14O + H: 151.11, found 151.0; [𝛼] = -2.23 ± 0.438 (c = 0.493 
M, dichloromethane) 
1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide: [𝛼] = 49.68 (c = 
0.471, dichloromethane) 
Yield: 30.4 mg (20.2%); IR(neat) νmax (cm
-1): 2955.4, 2924.4, 2869.9, 1734.24 
MS m/z: [M+H]+ calculated for C10H14O + H: 151.11, found 152.0. Fragments: 137.1, 
55.0; 1H NMR (500 MHz, CDCl3) δ (ppm): 2.16 (1H, m), 2.04 (1H, m), 1.62 (1H, M), 
1.56 (1H, m), 1.39 (1H, m), 1.36 (1H, m), 1.32 (1H, m), 1.30 (1H, m), 1.26 (2H, m), 1.91 
(1H, m), 0.96 (1H, m), 0.90 (1H, m), 0.82 (1H, m); [𝛼] = 29.13 ±1.74 (c = 0.230, 
dichloromethane) 
1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide: [𝛼] = 1.29 (c = 0.459, 
dichloromethane) 
Yield: 18.4 mg (12.2%); IR(neat): 2933.7, 2855.9, 1729.1; MS m/z: [M+H]+ calculated 
for C10H14O + H: 151.11, found 150.9; 
1H NMR (500 MHz, CDCl3) δ (ppm): 2.22 (1H, 
m), 2.17 (1H, m), 2.04 (1H, m), 1.90 (1H, m), 1.67 (1H, m), 1.55 (1H, m), 1.51 (1H, m), 
1.41 (1H, m), 1.38 (1H, m), 1.35 (2H, m), 1.15 (1H, m), 0.94 (1H, m), 0.85 (1H, m); [𝛼] 
= -10.87 ± 4.83 (c = 0.046, dichloromethane) 
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1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide: [𝛼] = 2.21 (c = 0.473, 
dichloromethane)  
Product determined by comparing its GC retention time with product 7 completed in the 
achiral environment. 
Yield: 18.1 mg (12.1%); IR(neat) νmax (cm
-1): 2961.1, 2926.9, 2855.1, 1727.9; MS m/z: 
[M+H]+ calculated for C10H14O + H: 151.11, found 150.9. Fragments: 149, 55; [𝛼] = -
2.53 ± 0.688 (c = 0.316, dichloromethane) 
6-Methyltricyclo[5.4.0.02,6]undecan-3-one (8) 
2-Cyclopentenone (0.04 mL, 0.5 mmol) and cyclohexene (0.76 mL, 7.5 mmol) were 
dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg 
lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.00 (c = 0.799, dichloromethane) 
Product determined by comparing its GC retention time to compound 8 completed in the 
achiral environment. 
Yield:  16.4 mg (10%); IR(neat) νmax (cm
-1): 2926.8, 2854.3, 1730.6; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.1; [𝛼] = -5.45 ± 1.01 (c = 0.220, 
dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.14 (c = 0.849, dichloromethane) 
Product determined by comparing its GC retention time to compound 8 completed in the 
achiral environment. 
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Yield:  17.4 mg (10.6%); IR(neat) = νmax (cm
-1): 2907.8, 2868.0, 1694.6; MS m/z: 
[M+H]+ calculated for C11H16O + H: 165.13, found 165.9; [𝛼] = -3.27 ± 0.999 (c = 
0.107, dichloromethane) 
1-butyl-3-methylimidazolium S-camphorsulfonate: [𝛼] = 18.21 (c = 0.494, dichloromethane) 
 Yield: 33.9 mg (20.6%); IR(neat) νmax (cm
-1): 2926.6, 2854.3, 1730.0 
MS m/z: [M+H]+ calculated for C11H16O + H: 165.13, found 165.1. Fragments: 311.3, 
83.1; 1H NMR (500 MHz, CDCl3) δ (ppm): 2.94 (1H, m), 2.84 (1H, m), 2.69 (1H, m), 
2.59 (1H, m), 2.45 (1H, m), 2.32 (1H, m), 2.20 (1H, m), 2.04 (1H, m), 1.96 (1H, m),1.84 
(1H, m), 1.73 (1H, m), 1.62 (1H, m), 1.55 (1H, m), 1.45 (1H, m), 1.37 (1H, m), 1.22 (1H, 
m); [𝛼] = -1.18  ± 0.303 (c = 0.678, dichloromethane) 
R-2-amino-N,N,N-trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate: [𝛼] = -8.33 (c = 108, 
dichloromethane) 
Product determined by comparing its GC retention time to compound 8 completed in the 
achiral environment. 
Yield: 20.9 mg (12.7%); IR(neat) νmax (cm
-1): 2927.3, 2855.0, 1728.7; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.1; [𝛼] = -2.73 ± 0.665 (c = 0.330, 
dichloromethane) 
1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide: [𝛼] = 49.68 (c = 
0.471, dichloromethane) 
Yield: 208.9 mg (>99%); IR(neat) νmax (cm-1): 2927.0, 2855.1, 1731.3; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.1. Fragments: 83.1; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.93 (1H, m), 2.77 (1H, m), 2.70 (1H, m), 2.60 (1H, m), 2.45 (1H, m), 
2.34 (1H, m), 2.21 (1H, m), 2.06 (1H, m), 1.96 (1H, m), 1.86 (1H, m), 1.74 (1H, m), 1.63 
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(1H, m), 1.54 (1H, m), 1.48 (1H, m), 1.39 (1H, m), 1.26 (1H, m); [𝛼] = 3.97 ± 0.103 (c = 
0.208, dichloromethane) 
1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide: [𝛼] = 1.29 (c = 0.459, 
dichloromethane) 
Yield: 17.4 mg (10.6%); IR(neat) νmax (cm
-1): 2926.8, 2854.9, 1732.6 
MS m/z: [M+H]+ calculated for C11H16O + H: 165.13, found 165.1; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.94 (1H, m), 2.77 (1H, m), 2.71 (1H, m), 2.61 (1H, m), 2.50 (1H, m), 
2.33 (1H, m), 2.20 (1H, m), 2.02 (1H, m), 1.96 (1H, m), 1.87 (1H, m), 1.72 (1H, m), 1.62 
(1H, m), 1.55 (1H, m), 1.40 (1H, m), 1.38 (1H, m), 1.26 (1H, m); [𝛼] =  -2.29 ± 0.601 (c 
= 0.348, dichloromethane) 
1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide: [𝛼] = 2.21 (c = 0.473, 
dichloromethane) 
Yield: 20.4 mg (12.4%); IR(neat) νmax (cm
-1): 2926.9, 2854.4, 1730.4; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.1. Fragments: 83.1, 55; 
1H NMR (500 
MHz, CDCl3) δ (ppm): 2.94 (1H, m), 2.76 (1H, m), 2.70 (1H, m), 2.59 (1H, m), 2.46 (1H, 
m), 2.36 (1H, m), 2.29 (1H, m), 2.20 (1H, m), 2.04 (1H, m), 1.96 (1H, m), 1.88 (1H, m), 
1.76 (1H, m), 1.62 (1H, m), 1.48 (1H, m), 1.38 (1H, m), 1.25 (1H, m); [𝛼] = -2.94 ± 
0.522 (c = 0.408, dichloromethane) 
Tricyclo[6.3.0.02,7]undecane-3-one (9) 
2-Cyclohexenone (0.05 mL, 0.5 mmol) and cyclopentene (0.66 mL, 7.5 mmol) were 
dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg 
lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
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gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.25 (c = 0.990, dichloromethane) 
Yield: 48.5 mg (30%); IR(neat) νmax (cm
-1): 2928.3, 2854.3, 1700.6; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.0. Fragments: 97.1; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.62 (1H, m), 2.58 (1H, m), 2.45 (1H, m), 2.19 (1H, m), 2.05 (1H, m), 
1.90 (1H, m), 1.85 (1H, m), 1.80 (1H, m), 1.75 (1H, m), 1.72 (1H, m), 1.66 (1H, m), 1.60 
(1H, m), 1.58 (1H, m), 1.37 (1H, m), 1.30 (1H, m), 1.28 (1H, m); [𝛼] = -2.00 ± 0.279 (c 
= 0.204, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.02 (c = 1.029, dichloromethane) 
Product determined by comparing its GC retention time to compound 9 completed in the 
achiral environment. 
Yield: 8.9 mg (5%); IR(neat) νmax (cm
-1): 2924.6, 2853.4, 1740.1; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.0; [𝛼] = -15 ± 4.10 (c = 0.053, 
dichloromethane) 
Tricyclo[6.4.0.02,7]dodecan-3-one (10) 
2-Cyclohexenone (0.05 mL, 0.5 mmol) and cyclohexene (0.76 mL, 7.5 mmol) were 
dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg 
lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
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1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.25 (c = 0.990, dichloromethane) 
Product determined by comparing its GC retention time to compound 10 completed in the 
achiral environment. 
Yield: 4.1 mg (2.30%); IR(neat) νmax (cm
-1): 2986.8, 2845.8, 1702.1; MS m/z: [M+H]+ 
calculated for C12H18O + H: 179.14, found 178.9. Fragments: 150.8; [𝛼] = -2.29 ± 1.23 
(c = 0.136, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.02 (c = 1.029, dichloromethane) 
Yield: 18.9 mg (11%); IR(neat) νmax (cm
-1): 2924.1, 2854.3, 1743.9; MS m/z: [M+H]+ 
calculated for C12H18O + H: 179.14, found 179.1. Fragments: 150.0; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.41 (1H, m), 2.36 (1H, m), 2.25 (1H, m), 2.18 (1H, m), 1.06 (1H, m), 
1.92 (1H, m), 1.85 (1H, m), 1.74 (1H, m), 1.64 (1H, m), 1.76 (1H, m) 1.64 (1H, m), 1.62 
(1H, m), 1.58 (1H, m), 1.55 (1H, m), 1.51 (1H, m), 1.46 (1H, m), 1.39 (1H, m), 1.33 (1H, 
m); [𝛼] = -4.46 ± 2.39 (c = 0.112, dichloromethane) 
7,7-dichlorobicyclo[4.2.0]octan-2-one (11) 
2-Cyclohexenone (0.05 mL, 0.5 mmol) and 1,1-dichloroethylene (0.6 mL, 7.5 mmol) 
were dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a 
Hg lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.24 (c = 0.955, dichloromethane) 
Product determined by comparing its GC retention time to compound 11 completed in the 
achiral environment. 
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Yield: 10.1 mg (5.64%); IR(neat) νmax (cm
-1): 2926.3, 2854, 1725.4, 740.0, 705.5 
MS m/z: [M+H]+ calculated for C8H12Cl2 + H: 179.04, found 179.8. Fragments: 144.6, 
109.0; [𝛼] = -4.45 ± 1.08 (c = 0.202, dichloromethane), ee = 3.3%. 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -17.08 (c = 0.562, dichloromethane) 
Product determined by comparing its GC retention time to compound 11 completed in the 
achiral environment. 
Yield: 74.8 mg (41.8%); IR(neat) νmax (cm
-1): 2930.6, 2870.8, 1734.1, 870.1, 814.6; MS 
m/z: [M+H]+ calculated for C8H12Cl2 + H: 179.04, found 179.8. Fragments: 144.5, 109.0; 
[𝛼] = -3.30 ± 0.100 (c = 0.212, dichloromethane), ee = 2.4%.  
6-Methyltricyclo[5.3.0.02,6]decan-3-one (12) 
3-Methyl-2-cyclopentenone (0.05 mL, 0.5 mmol) and cyclopentene (0.66 mL, 7.5 mmol) 
were dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a 
Hg lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.24 (c = 0.955, dichloromethane) 
Yield: 7.7 mg (4.3%); IR(neat) νmax (cm
-1): 2958.7, 2925.2, 2855.6, 1734.6; MS m/z: 
149.9 [M+H]+ calculated for C11H16O + H: 165.13, found 165.9; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.68 (1H, m), 2.52 (1H, m), 2.24 (1H, m), 2.01 (1H, m), 1.82 (1H, m), 
1.76 (1H, m), 1.72 (1H, m), 1.69 (1H, m), 1.68 (1H, m), 1.64 (1H, m), 1.60 (1H, m), 1.42 
(1H, m), 1.38 (1H, m), 0.89 (3H, s); [𝛼] = -3.38 ± 0.944 (c = 0.236, dichloromethane) 
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1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.24 (c = 0.420, dichloromethane) 
Yield: 16.7 mg (10.2%); IR(neat) νmax (cm
-1): 2963.7, 2926.6, 1733.4; MS m/z: [M+H]+ 
calculated for C11H16O + H: 165.13, found 165.1; 
1H NMR (500 MHz, CDCl3) δ (ppm): 
2.92 (1H, m), 2.50 (1H, m), 2.29 (1H, m),1.97 (1H, m), 1.81 (1H, m), 1.78 (1H, m), 1.72 
(1H, m), 1.69 (1H, m), 1.67 (1H, m), 1.64 (1H, m), 1.60 (1H, m), 1.41 (1H, m), 1.30 (1H, 
m), 0.97 (3H, s); [𝛼] = -2.73 ± 0.825 (c = 0.256, dichloromethane) 
6-Methyltricyclo[5.4.0.02,6]undecane-3-one (13) 
3-Methyl-2-cyclopentenone (0.05 mL, 0.5 mmol) and cyclohexene (0.76 mL, 7.5 mmol) 
were dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a 
Hg lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.09 (c = 1.060, dichloromethane) 
Yield: 19.4 mg (10.9%); IR(neat) νmax (cm
-1): 2929.3, 2856.4, 1730.7; MS m/z: 164.9, 
137.1 [M+H]+ calculated for C12H18O + H: 179.14, found 179.1; 
1H NMR (500 MHz, 
CDCl3) δ (ppm): 2.62 (1H, m), 2.52 (1H, m), 2.41 (1H, m), 2.31 (1H, m), 2.19 (1H, m), 
2.02 (1H, m), 1.97 (1H, m), 1.86 (1H, m), 1.76 (1H, m),  1.67 (1H, m), 1.62 (1H, m), 1.58 
(1H, m), 1.51 (1H, m), 1.41 (1H, m), 1.38 (1H, m), 0.88 (3H, s); [𝛼] = -1.55 ± 0.534 (c = 
0.388, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.24 (c = 0.420, dichloromethane) 
Yield: 74.8 mg (41.9%); IR(neat) νmax (cm
-1): 2930.6, 2857.6, 1731.5; MS m/z: [M+H]+ 
calculated for C12H18O + H: 179.14, found 179.1; 
1H NMR (500 MHz, CDCl3) δ (ppm): 
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2.61 (1H, m), 2.50 (1H, m), 2.41 (1H, m), 2.33 (1H, m), 2.18 (1H, m), 2.04 (1H, m), 1.90 
(1H, m), 1.87 (1H, m), 1.76 (1H, m), 1.66 (1H, m), 1.60 (1H, m), 1.57 (1H, m), 1.55 (1H, 
m), 1.46 (1H, m), 1.38 (1H, m), 0.88 (3H, s); [𝛼] = -0.94 ± 0.272 (c = 0.748, 
dichloromethane) 
7-Methyltricyclo[6.3.0.02,7]undecane-3-one (14) 
3-Methyl-2-cyclohexenone (0.057 mL, 0.5 mmol) and cyclopentene (0.66 mL, 7.5 mmol) 
were dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a 
Hg lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.81 (c = 0.930, dichloromethane) 
Yield: 22.1 mg (12.4%); IR(neat) νmax (cm
-1): 2930.6, 2855.4, 1698.7; MS m/z: 164.9 
[M+H]+ calculated for C12H18O + H: 179.14, found 179.1; 
1H NMR (500 MHz, CDCl3) δ 
(ppm):  3.21 (1H, dddd, J = 1.5, 6.5), 2.71 (1H, d, J = 9.4), 2.66 (1H, m), 2.51 (1H, m), 
2.36 (1H, m), 2.20 (1H, m), 2.17 (1H, m), 2.08 (1H, m), 1.96 (1H, m), 1.84 (1H, m), 1.81 
(1H, m), 1.67 (1H, m), 1.56 (1H, m), 1.43 (1H, m), 1.31 (1H, m), 0.94 (3H, s); [𝛼] = -
1.36 ± 0.467 (c = 0.442, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.24 (c = 0.420, dichloromethane) 
Yield: 82.1 mg (46.1%); IR(neat) νmax (cm
-1): 2950.2, 2869.9, 1685.7; MS m/z: 165.0 
[M+H]+ calculated for C12H18O + H: 179.14, found 179.9; 
1H NMR (500 MHz, CDCl3) δ 
(ppm): 3.10 (1H, m), 2.80 (1H, m), 2.66 (1H, m), 2.51 (1H, m), 2.36 (1H, m), 2.29 (1H, 
m), 2.19 (1H, m), 2.08 (1H, m), 2.01 (1H, m), 1.94 (1H, m), 1.84 (1H, m), 1.76 (1H, m), 
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1.67 (1H, m), 1.55 (1H, m), 1.30 (1H, m), 0.94 (3H, s); [𝛼] = -0.97 ± 0.246 (c = 0.821, 
dichloromethane) 
7-Methyltricyclo[6.4.0.02,7]dodecan-3-one (15) 
3-Methyl-2-cyclohexenone (0.057 mL, 0.5 mmol) and cyclohexene (7.5 mmol) were 
dissolved in the chiral ionic liquid (1 mL) in a Pyrex irradiation tube and irradiated with a Hg 
lamp for 24 hours. Diethyl ether (5 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE silica 
gel filter to remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product after purification by column chromatography. 
1-butyl-3-methylimidazolium L-Lactate: [𝛼] = -5.81 (c = 0.930, dichloromethane) 
Yield: 68.1 mg (35.4%); IR(neat) νmax (cm
-1): 2930.5, 2855.3, 1698.6; MS m/z: [M+H]+ 
calculated for C13H20O + H: 193.16, found 193.1; 
1H NMR (500 MHz, CDCl3) δ (ppm): 
2.67 (1H, m), 2.61 (1H, d, J = 10.3), 2.53 (1H, d, J = 9.0), 2.41 (2H, m), 2.37 (1H, m), 
2.28 (2H, m), 2.06 (2H, m), 1.95 (1H, m), 1.89 (2H, m), 1.60 (1H, m), 1.53 (1H, m), 1.47 
(1H, m), 1.38 (1H, m), 0.88 (3H, s); [𝛼] = -1.47 ± 0.299 (c = 0.681, dichloromethane) 
1-butyl-3-methylimidazolium R-camphorsulfonate: [𝛼] = -20.24 (c = 0.420, dichloromethane) 
Product determined by comparing its GC retention time to compound 15 completed in the 
achiral environment. 
Yield: 21.5 mg (11%); IR(neat) νmax (cm
-1): 2929.5, 2857.1, 2835.5, 16.48.5; MS m/z: 





5.2.3 Experimental for Chapter Four 
General Method for Achiral Reactions  
Two equivalents of the aldehyde/ketone and one equivalent of the base were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) 
was added to the mixture and then the mixture was washed with distilled water (5 mL), brine (5 
mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) and the 
combined organic products were dried over magnesium sulfate. Excess solvent was removed by 
the rotatory evaporator to result in the product after purification by column chromatography. The 
CIL used for each case is listed followed by the characterization of the product. 
3-Hydroxy-2-methylpentanal (16) 
A. Propanal (0.36 mL, 5 mmol) and morpholine (0.22 mL, 2.5 mmol) were added to  
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 31.0 mg (10.7%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 3421.4, 2962.27, 2878.9, 1654.1; MS m/z: 89.7 [M+H]+ calculated 
for C6H12O2 + H: 117.09, found 117.1; 
1H NMR(500MHz, CDCl3) δ (ppm):  9.20 (1H, s), 
3.70 (1H, m), 2.59 (1H, m), 1.59 (2H, m), 1.45 (1H, m), 0.93 (3H, t, J = 7.5), 0.83 (3H, d, 
J = 7); [𝛼]: -1.48 ± 1.24 (c = 0.203, dichloromethane) 
B. Propanal (0.36 mL, 5 mmol) and pyrroldine (0.21 mL, 2.5 mmol) were added to DMF (5 
mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) was 
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added to the mixture and then the mixture was washed with distilled water (5 mL), brine 
(5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) and 
the combined organic products were dried over magnesium sulfate. Excess solvent was 
removed by the rotatory evaporator to result in 16.8 mg (5.8%) of the product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3433.1, 2960.11, 2925.9, 1684.1; MS m/z: [M+H]+ calculated for 
C6H12O2 + H: 117.09, found 117.9; 
1H NMR(500 MHz, CDCl3) δ (ppm): 9.25 (1H, s), 
4.10 (1H, td), 3.71 (1H, bs), 2.19 (1H, m), 1.65 (2H, m), 0.98 (3H, t, J = 7.5), 0.87 (3H, d, 
J = 7);  [𝛼]: -1.36 ± 1.42 (c = 0.086, dichloromethane) 
2-Ethyl-3-hydroxyhexanal (17) 
A. Butanal (0.45 mL, 5 mmol) and morpholine (0.22 mL, 2.5 mmol) were added to DMF (5 
mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) was 
added to the mixture and then the mixture was washed with distilled water (5 mL) and 
brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) 
and the combined organic products were dried over magnesium sulfate. Excess solvent 
was removed by the rotatory evaporator to result in 24.1 mg (6.7%) the product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3405.7, 2961.8, 2932.9, 2874.0, 1718.2; MS m/z: [M+H]+ calculated 
for C8H16O2 + H: 145.12, found: 145.0; 
1H NMR(500 MHz, CDCl3) δ (ppm): 9.64 (1H, 
s), 3.87 (1H, bs), 3.64 (1H, m), 2.47 (1H, m), 1.98 (2H, m), 1.70 (2H, m), 1.25 (3H, m), 
1.10 (2H, m), 0.88 (3H, m); [𝛼]: -0.249 ± 0.251 (c = 0.482, dichloromethane) 
B. Butanal (0.45 mL, 5 mmol) and pyrrolidine (0.21 mL, 2.5 mmol) were added to DMF (5 
mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) was 
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added to the mixture and then the mixture was washed with distilled water (5 mL), brine 
(5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) and 
the combined organic products were dried over magnesium sulfate. Excess solvent was 
removed by the rotatory evaporator to result in 32.1 mg (8.9%) of the product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3446.9, 2962.7, 2874.0, 1716.8; MS m/z: 72.2 [M+H]+ calculated 
for C8H16O2 + H: 145.12, found: 145.0; 
1H NMR(500 MHz, CDCl3) δ (ppm): 9.64 (1H, 
s), 4.13 (1H, bs), 3.89 (1H, m), 2.25 (1H, m), 1.64 (2H, m), 1.36 (2H, m), 1.24 (3H, m), 
1.01 (2H, m), 0.86 (3H, m); [𝛼]: 0 ± 0 (c = 0.492, dichloromethane) 
3-Hydroxy-2-2-propylheptanal (18) 
A. Pentanal (0.27 mL, 5 mmol) and morpholine (0.22 mL, 2.5 mmol) were added to DMF (5 
mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) was 
added to the mixture and then the mixture was washed with distilled water (5 mL), brine 
(5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) and 
the combined organic products were dried over magnesium sulfate. Excess solvent was 
removed by the rotatory evaporator to result in 13.7 mg (3.2%) of the product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3439.0, 2957.4, 2931.6, 2871.6, 1759.1; MS m/z: 156.1, 72.2 
[M+H]+ calculated for C10H20O2 + H: 173.15, found: 173.0; 
1H NMR (500 MHz, CDCl3) 
δ (ppm): 9.19 (1H, s), 3.64 (1H, m), 2.59 (2H, m), 2.30 (1H, m), 1.92 (2H, m), 1.82 (1H, 
bs), 1.69 (2H, m), 1.46 (2H, m), 1.32 (2H, m), 0.94 (3H, m), 0.80 (3H, m); [𝛼]: 0 ± 0 (c = 
0.274, dichloromethane) 
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B. Pentanal 0.27 mL, 5 mmol) and pyrroldine (0.21 mL, 2.5 mmol) were added to DMF (5 
mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) was 
added to the mixture and then the mixture was washed with distilled water (5 mL), brine 
(5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) and 
the combined organic products were dried over magnesium sulfate. Excess solvent was 
removed by the rotatory evaporator to result in 26.1 mg (6.1%) of the product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3496.2, 2960.6, 2933.6, 2873.9, 1756.7; MS m/z: 156.1, 88.2 
[M+H]+ calculated for C10H20O2 + H: 173.15, found: 173.0; 
1H NMR(500MHz, CDCl3) δ 
(ppm): 9.49 (1H, s), 4.21 (1H, m), 2.33 (1H, m), 2.27 (2H, m), 1.72 (2H, m), 1.59 (2H, 
m), 1.46 (2H, m), 1.33 (2H, m), 1.24 (1H, s), 0.96 (3H, m), 0.90 (3H, m); [𝛼]: -0.380 ± 
0.383 (c = 0.402, dichloromethane) 
2-(1-Hydroxycyclopentyl)cyclopentanone (19) 
A.  Cyclopentanone (0.44 mL, 5 mmol) and morpholine (0.22 mL, 2.5 mmol) were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 11.4 mg (2.7%) of the 
product after purification by column chromatography. 
Product determined by comparing its GC retention time to compound 19A completed in 
the CIL 2S. 
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IR(neat) νmax (cm
-1): 3421.5, 2922.5, 2850.0, 1705.8; MS m/z: 153.1, 84.1, 72.2 [M+H]+ 
calculated for C10H16O2 + H: 169.12, found: 168.9; [𝛼]: 0 ± 0 (c = 0.228, 
dichloromethane) 
B. Cyclopentanone (0.44 mL, 5 mmol) and pyrrolidine (0.21 mL, 2.5 mmol) were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 25.5 mg (6.1%) of the 
product after purification by column chromatography.  
Product determined by comparing its GC retention time to compound 19B completed in 
the CIL 2S. 
IR(neat) νmax (cm
-1): 3455.1, 2959.2, 2872.0, 1706.3; MS m/z: 153.1, 72.2 [M+H]+ 
calculated for C10H16O2 + H: 169.12, found: 168.9; [𝛼]: -1.77 ± 1.47 (c = 0.282, 
dichloromethane) 
4-Hydroxy-3,4-dimethyl-2-hexanone (20) 
A. 2-Butanone (0.45 mL, 5 mmol) and morpholine (0.22 mL, 2.5 mmol) were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 10.5 mg the crude product.  
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B. 2-Butanone (0.45 mL, 5 mmol) and pyrroldine (0.21 mL, 2.5 mmol) were added to DMF 
(5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 mL) 
was added to the mixture and then the mixture was washed with distilled water (5 mL), 
brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 mL) 
and the combined organic products were dried over magnesium sulfate. Excess solvent 
was removed by the rotatory evaporator to result in the 8.9 mg (2.5%) product after 
purification by column chromatography. 
IR(neat) νmax (cm
-1): 3447.2,  2963.8, 2928.5, 1700.6; MS m/z: [M+H]+ calculated for 
C8H16O2 + H: 145.12, found: 145.1; [𝛼]: 0 ± 0 (c = 0.178, dichloromethane) 
5-Ethyl-5-hydroxy-4-methylhepta-1,6-dien-3-one (21) 
A. 1-Penten-3-one (0.25 mL, 5mmol) and morpholine (0.22 mL, 2.5 mmol) were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 31.5 mg (7.4%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1): 2968.3, 2936.9, 2851.1, 1718.9; MS m/z: 72.2 [M+H]+ calculated 
for C10H16O2 + H: 169.12, found: 168.9; [𝛼]: 0 ± 0 (c = 0.630, dichloromethane) 
B. 1-Penten-3-one (0.25 mL, 5mmol) and pyrrolidine (0.21 mL, 2.5 mmol) were added to 
DMF (5 mL). The mixture was stirred at room temperature for 24 hours. Diethyl ether (5 
mL) was added to the mixture and then the mixture was washed with distilled water (5 
mL), brine (5 mL). The aqueous layers were back extracted with dichloromethane (3 × 5 
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mL) and the combined organic products were dried over magnesium sulfate. Excess 
solvent was removed by the rotatory evaporator to result in 16.3 mg (3.8%) of the 
product after purification by column chromatography. 
IR(neat) νmax (cm
-1):  2966.8, 2938.8, 2850.3, 1720.6; MS m/z: 72.2 [M+H]+ calculated 
for C10H16O2 + H: 169.12, found: 168.9; [𝛼]: 0 ± 0 (c = 0.326, dichloromethane) 
General Method for Chiral Reactions 
 Two equivalents of the aldehyde/ketone and one equivalent of the base were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. Diethyl 
ether (3 × 1 mL) was added to the mixture to remove the organic component from the chiral 
ionic liquid. The organic mixture was injected through an SPE silica gel filter to remove any 
excess chiral ionic liquid. The product was dissolved in diethyl ether (3 mL) and washed with 
water (3mL) followed by brine (3 mL). The aqueous layers were back extracted with 
dichloromethane (3× 3 mL) and the combined organic products were dried over magnesium 
sulfate. Excess solvent was removed by the rotatory evaporator to result in the product. 
3-Hydroxy-2-methylpentanal (16) 
A. Propanal (0.18 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
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result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium R-Camphorsulfonate: [𝛼] = -20.24 (c = 0.420, 
dichloromethane) 
Yield: 27.7 mg (19.1%) of product and product with the enamine attached. 
IR(neat) νmax (cm
-1): 3373.34, 2960.0, 2924.5, 2855.5, 1725.2; MS m/z: [M+H]+ 
calculated for C7H14NO + H: 128.10, found 128.1. [M+H]
+ calculated for 
C10H18NO + H: 168.13, found 168.13; 
1H NMR (500 MHz, CDCl3) δ (ppm): 9.20 
(1H, s), 3.69 (1H, m), 3.17 (1H, m), 2.62 (1H, m), 1.59 (1H, m), 1.40 (1H, m), 
0.95 (3H, t, J = 7), 0.88 (3H, d, J = 6.5); [𝛼] = -4.89 ± 1.43 (c = 0.163, 
dichloromethane), 33% ee. 
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.21 (c = 0.494, 
dichloromethane) 
Yield: 111.5 mg (76.8%) of the product and product with enamine still attached; 
IR(neat) νmax (cm
-1): 3416.7, 2964.9, 2877.9, 1736.6; MS m/z: [M+H]+ calculated 
for C7H14NO + H: 128.10, found 128.1. [M+H]
+ calculated for C10H18NO + H: 
168.13, found 168.13. [M+H]+ calculated for C10H20NO2 + H: 186.14, found 
186.1; 1H NMR (500 MHz, CDCl3) δ (ppm): 9.21 (1H, s), 3.69 (1H, m), 2.58 (1H, 
m), 1.61 (2H, m), 1.45 (1H, m), 0.93 (3H, t, J = 7.5), 0.82 (3H, d, J = 7); [𝛼] = -




R-2-amino-N,N,N-trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate: [𝛼] = -10.52 
(c = 0.812, dichloromethane) 
Yield: 24.6 (16%) of the product with the enamine attached; IR(neat) νmax (cm
-1): 
3452.7, 2961.8, 2932.4, 1637.1; MS m/z: [M+H]+ calculated for C10H18NO + H: 
168.13, found 168.13; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.32 (1H, m), 6.02 
(1H, m), 4.85 (1H, m), 4.68 (1H, m), 3.69 (4H, m), 3.33 (1H, m), 2.46 (2H, m), 
1.86 (3H, m), 1.70 (1H, m),  1.51 (1H, m), 0.93 (3H, m); [𝛼] = -1.37 ± 0.479 (c = 
0.436, dichloromethane), 9% ee. 
1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide: [𝛼] = 50.37 
(c = 0.812, dichloromethane) 
Yield: 25.6 mg (17.6%) of the product; IR(neat) νmax (cm
-1): 3421.2, 2955.3, 
2722.6, 1736.9; MS m/z: [M+H]+ calculated for C6H12O2 + H: 117.09, found 
117.1; 1H NMR (500MHz, CDCl3) δ (ppm): 9.20 (1H, s), 4.02 (1H, t), 3.28 (1H, 
td), 2.16 (1H, m), 1.64 (1H, m), 1.36 (1H, m), 0.95 (3H, t, J = 7.5), 0.88 (3H, d, J 
= 7); [𝛼] = 32.42 ± 1.03 (c = 0.330, dichloromethane) 
1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide: [𝛼] = 1.29 (c = 
0.459, dichloromethane) 
Yield: 91.6 mg (64.3%) of the product and product with the enamine attached; 
IR(neat) νmax (cm
-1): 3447.0, 2965.7, 2852.0, 1683.8; MS m/z: [M+H]+ calculated 
for C7H14NO + H: 128.10, found 128.1. [M+H]
+ calculated for C10H18NO + H: 
168.13, found 168.13; 1H NMR (500 MHz, CDCl3) δ (ppm): 9.20 (1H, s), 3.69 
(1H, m), 3.11 (1H, td, Jt = 3.11, Jd = 2.45),  2.62 (1H, m), 1.63 (1H, m), 1.43 (1H, 
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m), 0.95 (3H, t, J = 7), 0.88 (3H, d, J = 6.5); [𝛼] = -0.295 ± 0.066 (c = 0.915, 
dichloromethane), 2% ee. 
1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide: [𝛼] = 2.21 (c = 0.473, 
dichloromethane) 
Yield: 22.0 mg (15.2%) of the product and product with the enamine attached; 
IR(neat) νmax (cm
-1): 3439.4, 2964.9, 2853.9, 1700.4; MS m/z: [M+H]+ calculated 
for C7H14NO + H: 128.10, found 128.1. [M+H]
+ calculated for C10H18NO + H: 
168.13, found 168.13; 1H NMR (500 MHz, CDCl3) δ (ppm): 9.51 (1H, s), 4.45 
(1H, m), 3.74 (1H, m), 2.05 (1H, bs), 1.63 (2H, m), 0.92 (3H, t), 0.81 (3H, d); [𝛼] 
= -1.73 ± 0.612 (c = 0.340, dichloromethane), 12% ee.  
B. Propanal (0.18 mL, 2.5 mmol) and pyrroldine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 




1-butyl-3-methylimidazolium R-Camphorsulfonate: [𝛼] = -20.24 (c = 0.420, 
dichloromethane) 
Yield: 14.8 mg (10.3%) of the product and product with the enamine attached; 
IR(neat) νmax (cm
-1): 3390.3, 2963.8, 2931.3, 2875.2, 1734.7; MS m/z: [M+H]+ 
calculated for C10H18N + H: 152.14, found 152.1; 
1H NMR (500 MHz, CDCl3); δ 
(ppm): 9.20 (1H, s), 3.69 (1H, m), 2.16 (1H, m), 1.65 (2H, m), 1.38 (1H, bs), 0.94 
(3H, t, J = 7.5), 0.80 (3H, d, J = 7); [𝛼] = -5.24 ± 1.06 (c = 0.210, 
dichloromethane), 35% ee. 
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] =19.71 (c = 0.695, 
dichloromethane) 
Yield: 84.3 mg (58.1%) of the product and product with the enamine attached. 
IR(neat) νmax (cm
-1): 3447.0, 2966.1, 2934.0, 2876.4, 1718.4 
MS m/z: [M+H]+ calculated for C10H18N + H: 152.14, found 152.1; 
1H NMR (500 
MHz, CDCl3) δ (ppm): 9.28 (1H, s), 4.10 (1H, m), 3.69 (1H, m), 2.80 (1H, m), 
1.65 (1H, m), 1.36 (1H, m), 0.94 (3H, t, J = 7.5), 0.88 (3H, d, J = 7); [𝛼] = 32.42 
± 1.03; [𝛼] = -3.50 ± 1.04 (c = 0.200, dichloromethane), 9% ee. 
S-2-amino-N,N,N-trimethyl-1-butanol-bis(trifluoromethanesulfon)imidate: [𝛼] = 7.80 (c = 
0.141, dichloromethane) 
Yield: 37.3 mg (25.7%) of the product and product with the enamine attached. 
IR(neat) νmax (cm
-1): 3458.6, 2961.8, 2932.4, 2854.4, 1637.1; MS m/z: [M+H]+ 
calculated for C10H18N + H: 152.14, found 152.1; 
1H NMR (CDCl3) δ (ppm): 9.20 
(1H, s), 4.02 (1H, m), 3.69 (1H, m), 2.62 (1H, m), 1.65 (1H, m), 1.23 (1H, m), 
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0.97 (3H, t, J = 7.5), 0.88 (3H, d, J = 7); [𝛼] = -1.34 ± 0.277 (c = 0.746, 
dichloromethane) 
1-butyl-3-menthoxymethylimidazolium bis(trifluoromethanesulfonyl)amide: [𝛼] = 50.37 
(c = 0.812, dichloromethane) 
Yield: 25.7 mg (17.7%) of the product and product with the enamine attached; 
IR(neat) νmax (cm
-1): 3401.3, 2956.5, 2923.2, 2870.4, 1680.2; MS m/z: [M+H]+ 
calculated for C10H18N + H: 152.14, found 152.0; 
1H NMR (500 MHz, CDCl3) δ 
(ppm): 9.21 (1H, s), 3.26 (1H, td, Jt = 10 Hz, Jd = 4.05 Hz), 2.16 (1H, m), 1.62 
(2H, m), 1.36 (1H, bs), 0.90 (3H, t, J = 7.5 Hz), 0.76 (3H, d, J = 7 Hz); [𝛼] = 
85.99 ± 0.931 (c = 0.514, dichloromethane) 
1-[(3R)-3,7-dimethyloct-6-enyl]-3-methyl-1H-imidazolium bromide: [𝛼] = 1.29 (c = 
0.459, dichloromethane) 
Yield: 14.9 (10.3%) of the product with the enamine attached; IR(neat) νmax (cm
-
1): 3387.9, 2927.4, 2854.3, 1718.4; MS m/z: [M+H]+ calculated for C10H18N + H: 
152.14, found 152.1; 1H NMR (500 MHz, CDCl3) δ (ppm): 10.1 (1H, s), 4.19 
(1H, s), 3.87 (1H, s), 2.62 (1H, m), 1.97 (2H, m), 0.95 (3H, t, J = 7.5), 0.87 (3H, 
d, J = 7); [𝛼] = -1.94 ± 1.03 (c = 0.206, dichloromethane), 13% ee. 
1-butyl-3-[(3R)-3,7-dimethyl-6-enyl]-1H-imidazolium bromide: [𝛼] = 2.21 (c = 0.473,  
dichloromethane) 
Product determined by comparing its GC retention time with compound 16B 
completed in CIL 5. 
Yield: 7.9 mg (5.4%) of the product and product with the enamine attached. 
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IR(neat) νmax (cm
-1): 3418.7, 2963.63, 2853.21, 1670.0; MS m/z: [M+H]+ 
calculated for C10H18N + H: 152.14, found 152.0; [𝛼] = -3.04 ± 0.840 (c = 0.263, 
dichloromethane), 21% ee.  
2-Ethyl-3-Hydroxyhexanal (17) 
A. Butanal (0.23 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 19.71 (c = 0.695, 
dichloromethane) 
Yield: 33.2 mg (18.4%); IR(neat) νmax (cm
-1): 3416.7, 2960.8, 2934.1, 2873.9, 
1685.1; MS m/z: 88.2 [M+H]+ calculated for C8H16O2 + H: 145.12, found: 145.0; 
1H NMR (500 MHz, CDCl3) δ (ppm): 9.41 (1H, s), 3.67 (1H, bs), 2.62 (1H, m), 
2.33 (1H, m), 1.89 (2H, m), 1.58 (2H, m), 1.39 (2H, m), 1.25 (3H, m),  0.88 (3H, 
m); [𝛼] = -3.01 ± 0.623 (c = 0.332, dichloromethane) 
B. Butanal (0.23 mL, 2.5 mmol) and pyrroldine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
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from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 19.71 (c = 0.695, 
dichloromethane) 
Yield: 36.1 mg (20.0%); IR(neat) νmax (cm
-1): 3481.4, 2960.7, 2874.1, 1718.4; ; 
MS m/z: 88.2 [M+H]+ calculated for C8H16O2 + H: 145.12, found: 145.1; 
1H 
NMR (500 MHz, CDCl3) δ (ppm): 9.20 (1H, s), 4.10 (1H, bs), 2.69 (1H, m), 2.33 
(1H, m), 1.80 (2H, m), 1.64 (2H, m), 1.39 (2H, m), 1.25 (3H, m),  0.88 (3H, m); 
[𝛼] = -6.42 ± 1.96 (c = 0.109, dichloromethane) 
3-Hydroxy-2-propylheptanal (18) 
A. Pentanal (0.27 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
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result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.53 (c = 0.804, 
dichloromethane) 
Product determined by comparing its GC retention time to compound 18A 
completed in the achiral environment. 
Yield:  51.6 mg (24.0%); IR(neat) νmax (cm
-1): 3490.1, 2965.1, 2873.4, 1782.2; 
MS m/z: 156.1 [M+H]+ calculated for C10H20O2 + H: 173.15, found: 173.0; [𝛼] = 
-6.06 ± 1.61 (c = 0.132, dichloromethane) 
B. Pentanal (0.27 mL, 2.5 mmol) and pyrroldine (0.11 mL, 1.25 mmol) were added to the 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] =18.53 (c = 0.804, 
dichloromethane) 
Product determined by comparing its GC retention time to compound 18B 
completed in the achiral environment. 
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Yield: 52.0 mg (24.2%); IR(neat) νmax (cm
-1): 3468.0, 2958.0, 2872.1, 1690.7; MS 
m/z: 72.2, 156.1 [M+H]+ calculated for C10H20O2 + H: 173.15, found: 173.1; [𝛼] 
= -3.49 ± 1.21 (c = 0.172, dichloromethane) 
2-(1-Hydroxycyclopentyl)cyclopentanone (19) 
A. Cyclopentanone (0.22 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added 
to the chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 
hours. Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The product was dissolved in diethyl ether (3 
mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. The organic mixture was injected through an SPE silica gel filter to 
remove any excess chiral ionic liquid. Excess solvent was removed by the rotatory 
evaporator to result in the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.53 (c = 0.804, 
dichloromethane) 
Yield: 12.2 mg (5.8%); IR(neat) νmax (cm
-1): 3447.0, 2958.4, 2924.6, 2855.0, 
1735.5; MS m/z: 153.1, 84.1, 72.2 [M+H]+ calculated for C10H16O2 + H: 169.12, 
found: 168.9; 1H NMR (500Mhz, CDCl3) δ (ppm): 5.12 (1H, m), 3.75 (2H, m), 
3.52 (2H, m), 3.22 (1H, bs), 3.01 (2H, m), 2.78 (2H, m), 2.62 (2H, m), 2.15 (2H, 
m), 1.88 (2H, m); [𝛼] = -9.74 ± 1.56 (c = 0.154, dichloromethane) 
B. Cyclopentanone (0.22 mL, 2.5 mmol) and pyrrolidine (0.11 mL, 1.25 mmol) were added 
to the chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 
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hours. Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE 
silica gel filter to remove any excess chiral ionic liquid. The product was dissolved in 
diethyl ether (3 mL) and washed with water (3mL) followed by brine (3 mL). The 
aqueous layers were back extracted with dichloromethane (3× 3 mL) and the combined 
organic products were dried over magnesium sulfate. Excess solvent was removed by the 
rotatory evaporator to result in the product. Excess solvent was removed by the rotatory 
evaporator to result in the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.53 (c = 0.804, 
dichloromethane) 
Yield: 13.5 mg (6.4%); IR(neat) νmax (cm
-1): 3424.9, 2922.5, 1700.5; MS m/z: 
153.1 [M+H]+ calculated for C10H16O2 + H: 169.12, found: 168.9; 
1H NMR 
(500Mhz, CDCl3) δ (ppm): 5.12 (1H, m), 3.69 (2H, m), 3.45 (2H, m), 3.22 (1H, 
bs), 2.99 (2H, m), 2.78 (2H, m), 2.59 (2H, m), 2.14 (2H, m), 1.89 (2H, m); [𝛼] = -
1.85 ± 0.769 (c = 0.270, dichloromethane) 
4-Hydroxy-3,4-dimethylhexan-3-one (20) 
A. 2-Butanone (0.23 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added to 
chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
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dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
15.0 mg of the crude product.  
B. 2-Butanone (0.23 mL, 2.5 mmol) and pyrrolidine (0.11 mL, 1.25 mmol) were added to 
the chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.56 (c = 0.726, 
dichloromethane) 
Yield: 10.0 mg (5.6%); IR(neat) νmax (cm
-1): 2959.5, 2925.7, 2854.6, 1772.86; MS 
m/z: [M+H]+ calculated for C8H16O2 + H: 145.12, found: 145.0; [𝛼] = -3.00 ± 
1.06 (c = 0.200, dichloromethane) 
5-Ethyl-5-hydroxy-4-methylhepta-1,6-dien-3-one (21) 
A. 1-Penten-3-one (0.25 mL, 2.5 mmol) and morpholine (0.11 mL, 1.25 mmol) were added 
to the chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 
hours. Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic 
component from the chiral ionic liquid. The organic mixture was injected through an SPE 
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silica gel filter to remove any excess chiral ionic liquid. The product was dissolved in 
diethyl ether (3 mL) and washed with water (3mL) followed by brine (3 mL). The 
aqueous layers were back extracted with dichloromethane (3× 3 mL) and the combined 
organic products were dried over magnesium sulfate. Excess solvent was removed by the 
rotatory evaporator to result in the product. Excess solvent was removed by the rotatory 
evaporator to result in the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] = 18.56 (c = 0.726, 
dichloromethane) 
Yield: 10 mg (4.7%); IR(neat) νmax (cm
-1): 2965.0, 2925.0, 1717.9; MS m/z: 72.2 
[M+H]+ calculated for C10H16O2 + H: 169.12, found: 168.9; [𝛼] = -4.77 ± 1.58 (c 
= 0.146, dichloromethane) 
B. 1-Penten-3-one (0.25 mL, 2.5 mmol) and pyrrolidine (0.11 mL, 1.25 mmol) were added 
to chiral ionic liquid (1 mL). The mixture was stirred at room temperature for 24 hours. 
Diethyl ether (3 × 1 mL) was added to the mixture to remove the organic component 
from the chiral ionic liquid. The organic mixture was injected through an SPE silica gel 
filter to remove any excess chiral ionic liquid. The product was dissolved in diethyl ether 
(3 mL) and washed with water (3mL) followed by brine (3 mL). The aqueous layers were 
back extracted with dichloromethane (3× 3 mL) and the combined organic products were 
dried over magnesium sulfate. Excess solvent was removed by the rotatory evaporator to 
result in the product. Excess solvent was removed by the rotatory evaporator to result in 
the product.  
1-butyl-3-methylimidazolium S-Camphorsulfonate: [𝛼] =18.56 (c = 0.726, 
dichloromethane) 
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Yield: 18.1 mg (8.5%); IR(neat) νmax (cm
-1): 2962.21, 2923.9, 1700.44; MS m/z: 
72.2 [M+H]+ calculated for C10H16O2 + H: 169.12, found: 168.9; [𝛼] = -1.38 
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Error analysis sample calculation for entry 3 from table 4: 




















= -0.40 ± 0.403 
 
